WO1999039663A1 - Endovascular graft for bridging a defect in a main vessel near one or more branch vessels - Google Patents

Endovascular graft for bridging a defect in a main vessel near one or more branch vessels Download PDF

Info

Publication number
WO1999039663A1
WO1999039663A1 PCT/US1999/002704 US9902704W WO9939663A1 WO 1999039663 A1 WO1999039663 A1 WO 1999039663A1 US 9902704 W US9902704 W US 9902704W WO 9939663 A1 WO9939663 A1 WO 9939663A1
Authority
WO
WIPO (PCT)
Prior art keywords
graft
stent
main vessel
apertures
renal
Prior art date
Application number
PCT/US1999/002704
Other languages
French (fr)
Inventor
Wilfrido R. Castaneda
Original Assignee
Envatech Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Envatech Corporation filed Critical Envatech Corporation
Priority to AU25928/99A priority Critical patent/AU2592899A/en
Publication of WO1999039663A1 publication Critical patent/WO1999039663A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/061Blood vessels provided with means for allowing access to secondary lumens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/075Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001Designing or manufacturing processes
    • A61F2240/002Designing or making customized prostheses

Definitions

  • the present invention generally relates to endovascular grafts and, more particularly, to a graft and process for bridging an abdominal aortic aneurysm disposed in the aorta near the renal arteries in which the graft is expanded against a portion of the aortic wall above one or both renal arteries.
  • Abdominal aortic aneurysms are potentially life threatening defects which generally lie in a section of the aorta between the renal arteries and the iliac arteries.
  • an abdominal aortic aneurysm may extend into either or both of the iliac arteries.
  • Abdominal aortic aneurysms are commonly treated using surgical techniques. Surgical treatment of abdominal aortic aneurysms is however a complicated procedure associated with high risk. As an alternative to surgery, a wide variety of grafts including, for example, stented grafts or stent-grafts, have been proposed for bridging and excluding abdominal aortic aneurysms. The use of these grafts is however limited. In most cases, an abdominal aortic aneurysm is either left untreated or is treated surgically. Even in cases using a graft, the procedure is sometimes terminated in favor of surgical treatment.
  • the present invention generally provides grafts for bridging a main vessel having a defect disposed near one or more branch vessels extending from the main vessel.
  • Embodiments of the invention are particularly suited for bridging abdominal aortic aneurysms having minimal or no proximal necks, a significant factor limiting the use of conventional grafts for bridging abdominal aortic aneurysms.
  • the stent-graft for bridging an aneurysm in an aorta disposed below two renal arteries.
  • the stent-graft includes a graft material defining two renal apertures each oriented to align with one of the two renal arteries when the stent-graft is in an expanded state.
  • the stent-graft further includes a stent system for supporting the graft material in a contracted state wherein the renal apertures are contracted and the expanded state wherein the renal apertures are expanded.
  • the stent system when in the expanded state is adapted to press against a portion of the aortic wall above the first renal artery and against a portion of the aortic wall above the second renal artery.
  • Each renal aperture may, for example, have an area as large as or larger than the opening of the respective renal artery.
  • the graft material defines a mesenteric aperture oriented to align with a superior mesenteric artery when the stent-graft is in an expanded state.
  • the stent-graft material further defines a celiac aperture oriented to align with a celiac axis artery when the stent-graft is in the expanded state.
  • a graft in accordance with another embodiment of the invention, includes a tubular member which defines one or more apertures and is adapted for positioning against a wall of a main vessel above one or more branch vessels.
  • Each aperture defined by the tubular member is alignable with at least one of the one or more branch vessels and has an area which is greater than the opening of the respective branch vessel(s) when the graft is positioned against the wall of the main vessel.
  • a process of bridging a defect disposed in a main vessel near one or more branch vessels is provided. Consistent with the process, a graft which defines one or more apertures is inserted in a contracted state within the main vessel. The graft is aligned within the main vessel such that each aperture aligns with at least a respective one of the branch vessels and expanded into a expanded state wherein the one or more apertures align with the one or more branch vessel and the graft presses against the main vessel wall.
  • the process can, for example, be used to bridge an abdominal aortic aneurysm disposed in an aorta near the renal arteries.
  • FIGS. 2A-2C illustrate an exemplary graft in accordance with one embodiment of the invention
  • FIGS. 3A-3C illustrate an exemplary graft in accordance with another embodiment of the invention
  • FIGS. 4A-4C illustrate an exemplary graft in accordance with another embodiment of the invention
  • Figure 6 illustrates an exemplary graft in accordance with still another embodiment of the invention.
  • FIGS. 7A-7D illustrate an exemplary process for deploying a graft in accordance with one embodiment of the invention
  • Figure 8 is a flow chart illustrating an exemplary manufacturing process in accordance with an embodiment of the invention.
  • Figure 9 illustrates a typical temperature vs. transformation curve for a shape memory alloy.
  • the present invention generally relates to endovascular grafts used for bridging a defect in a main vessel near one or more branch vessels.
  • the invention is particularly suited for bridging and excluding abdominal aortic aneurysms located near the renal arteries. While the present invention is not so limited, an appreciation of various aspects of the invention will be gained through a discussion of the examples provided below.
  • the invention provides a graft for bridging a defect disposed in a main vessel near one or more branch vessels.
  • the graft includes a tubular member which defines one or more apertures and is adapted for expansion against a portion of the main vessel wall above one or more branch vessels (i.e., against a portion of the main vessel wall opposite the defect).
  • Each aperture defined by the end portion is alignable with at least one of the one or more branch vessels and typically has an area which is as large as or larger than the orifice of the respective branch vessel(s) when the tubular member is expanded against the inner wall of the main vessel.
  • FIG. 1 illustrates a front view of a exemplary vascular section 100 having a typical abdominal aortic aneurysm 102.
  • the vascular section 100 includes an aorta 104 which bifurcates into two iliac arteries 106, a superior mesenteric artery 108, a celiac axis artery 110, and right and left renal arteries 112a and 112b, each of which branch off from the aorta 104.
  • the renal arteries 112a and 112b may lie at the same or different levels and may be single or multiple in number.
  • the right renal artery 112a is shown below the left renal artery 112b.
  • the abdominal aortic aneurysm 102 generally lies in a section of the aorta 104 below the right and left renal arteries 112a and 112b and above the iliac arteries 106. In some cases, the aneurysm 102 may extend into either or both of the iliac arteries 106. As is typical of many abdominal aortic aneurysms, the illustrated aneurysm 102 has no proximal neck (e.g., the aneurysm extends up to and abuts the lower edges 114a and 114b of the right and/or left renal arteries 112a and 112b).
  • Conventional grafts used to bridge abdominal aortic aneurysms typically have a proximal end designed for positioning against a proximal neck, i.e., a patent portion of the aortic wall below the renal arteries 112a and 112b.
  • necks greater than 10 millimeters (mm) are needed to reliably secure a conventional graft.
  • necks less than 5 mm conventional grafts typically cannot be reliably secured.
  • One conventional graft which attempts to address the problems associated with minimal proximal necks includes a webbed end which may be positioned slightly over the lower edge 114a of the right renal artery 112a.
  • the present invention overcomes the limitations of conventional grafts and provides an endovascular graft and process for bridging abdominal aortic aneurysms having minimal (e.g., less than 5 or 10 mm) or no proximal necks.
  • the main body 202 is configured to expand against portions 116 and 118 of the aortic wall 115 above the renal arteries 112a and 112b.
  • the term above is used herein to describe a vessel wall portion on a side of a branch vessel opposite the side of the branch vessel where a defect lies.
  • the stent system 214 (and main body 202) may take a variety of different forms.
  • the main body 202 In its expanded state, the main body 202 is configured to expand against portions 116 and 118 of the aortic wall 115 above the renal arteries 112a and 112b.
  • the graft material 210 is typically distensible such that the graft material 210 can adapt to the stent system 214 when the main body 202 is contracted and expanded.
  • the graft material 210 may be formed from a number of different well- known materials, such as DacronTM, GortexTM, polyethylene or polyurethane, for example.
  • the graft material 210 may be secured to the stent system 214 using, for example, well-known stitching, gluing or weaving techniques. While the invention is not so limited, the stent system may be disposed on the exterior or interior of the graft material 210, or within the graft material 210 itself.
  • the graft material 210 generally defines two renal apertures 212a and 212b each of which are alignable with a respective one of the renal arteries 112a and 112b when the main body 202 is expanded against the aortic wall.
  • the shapes, sizes and relative orientation of the renal apertures 212a and 212b can vary as will be discussed below.
  • the renal apertures 212a and 212b are each typically supported by a surrounding portion 218 of the stent system 214.
  • the surrounding portions 218 of the stent system 214 may be shaped similar to and completely surround the perimeters of the renal apertures 212a and 212b.
  • the renal apertures 212a and 212b may be supported by the surrounding portions 218 of the stent system 214 by, for example, stitching portions of the graft material 210 around the apertures 212a and 212b to the surrounding stent portions.
  • a tight seal can be formed between the graft material 210 and the aortic wall 115 around the renal artery orifices and leakage can be prevented.
  • the exemplary stent system 214 is formed of a wire (e.g., nitinol) mesh in a honeycomb pattern having a number of interconnected wire loops, two of the which form surrounding portions 218 and align with the renal apertures 212a and 212b in the graft material 210.
  • the proximal end 220 of the stent system 214 generally seals the main body 202 against the aortic wall 115, and may, for example, include a wire portion 222 interconnecting loops of stent system 214.
  • the stent system 214 may be formed of a number of different materials including, for example, metals and/or metal alloys.
  • the stent system 214 is formed from a shape-memory alloy (SMA), such as nitinol.
  • SMA shape-memory alloy
  • Shape- memory alloys have the ability to transform from a martensite phase shape (in which the stent system 214 may be deformed to a contracted state) to a parent or austenite phase (typically corresponding to the expanded state of the stent system 214).
  • An SMA may exhibit either one-way or two-way shape memory. With two-way shape memory, the SMA changes shape upon both heating and cooling. With one-way shape memory, the SMA undergoes shape change only upon heating. Upon cooling, the shape of the SMA does not spontaneously change, but may be changed by force.
  • the curve 900 typically includes a heating curve 910, on which the SMA specimen generally undergoes transformation from a martensite phase 912 to an austenite phase 914, and a cooling curve 930 on which the phase change is reversed. While the phase transformations take place over a relatively broad temperature range, the majority of phase transformation typically occurs over a relatively narrow temperature band.
  • the austenite start and finish (AS and AF) temperatures generally denote temperatures between which the majority of the martensite-to-austenite transformation on the heating curve 910 occurs.
  • the martensite start and finish (MS and MF) temperature denote similar temperatures on the cooling curve 930.
  • the transformation curve 900 exhibits hysteris T, (i.e., an offset between the heating and cooling curves 910 and 930).
  • the stent system 214 is formed from an SMA, such as nitinol, having a AF temperature of about body temperature or less (typically 37°C or less). This enables the stent system 214 to transform into its parent or austenite phase (typically corresponding to the expanded state of the stent system 214) when subject to body temperature.
  • the stent system 214 is formed from an SMA, such as nitinol, having an AF temperature greater than body temperature (e.g., an AF temperature of about 48°C).
  • the stent system 214 This enables the stent system 214 to be partially expanded to an intermediate state when between an AS temperature (e.g., 35°C) and the AF temperature and also allows the stent system 214 to be fully expanded when heated above the AF temperature.
  • AS temperature e.g., 35°C
  • the MS temperature of the stent system 214 is typically selected to be below body temperature (e.g., about 20°C) to prevent partial matertensite transformation when the stent system 214 returns to body temperature.
  • the stent system 214 may demonstrate one-way or two-way shape change.
  • each renal aperture 212a and 212b are located on the main body 202 such that, when expanded, the renal apertures 212a and 212b align with the renal artery orifices of a patient.
  • the size of each renal aperture 212a and 212b is typically selected to be at least as large as the orifice of its respective renal artery 112a and 112b.
  • the size of each renal aperture 212a and 212b can vary as the sizes of renal arteries can vary from patient to patient. Suitable sizes of the renal apertures 212a and 212b range from about 0.8 to 1.0 cm or more in diameter for many applications.
  • the use of renal apertures 212a and 212b which are larger than the renal artery orifices allows for variable position of the renal arteries from patient to patient and by allowing some tolerance in the deployment of the main body 202 of the stent-graft 200.
  • each aperture 212a and 212b can also vary and may, for example, be rectangular, circular, or ovular.
  • each aperture 212a and 212b is ovular in shape and has a length in the longitudinal direction which is greater than a circumferential width.
  • the length may be about 1.2 to 1.5 cm and the width about 1.0 to 1.2 cm.
  • each aperture 212a and 212b may have a length in the longitudinal direction which is less than a circumferential width.
  • the two renal apertures 212a and 212b may have different shapes and/or sizes. For example, one may be oval-shaped and extended in the longitudinal direction, while the other may be oval-shaped and extended in the circumferential direction.
  • stent system 214 can be designed to accommodate various shapes of the apertures 212a and 212b.
  • the relative orientation of the renal apertures 212a and 212b can vary as well.
  • the angle ⁇ (shown in Figure 2C) will be used to define the angular distance between the centers of the apertures 212a and 212b and the distance dj (shown in Figure 2B) will be used to define the distance between the centers of the apertures 212a and 212b along the longitudinal axis of the stent-graft 200.
  • Relative orientations having an angle ⁇ ranging between about 72 to 225 degrees, and more typically between about 140 and 185 degrees, and a distance d ranging from about 0 to 2 cm would be suitable for many applications.
  • Radiopaque markers may be placed on the main body 202 to facilitate identification of the main body 202 within the aorta 103.
  • radiopaque markers may be positioned near or around each renal aperture 212a and 212b to improve visualization and facilitate alignment of the apertures 212a and 212b. This may be done by, for example, soldering radiopaque material (e.g., gold or platinum) to the portions 218 of the stent system 214 surrounding the apertures 212a and 212b.
  • a radiopaque aligning system may also be placed on the stent-graft portion 210 to aid in aligning the main body 202 with a desired plane, such as the anterior-posterior or A-P plane.
  • a radiopaque diamond (0) may be placed on one side of the main body 202 and a radiopaque vertical line (
  • ) aligning system is illustrated in Figure 2A. A number of other arrangements, such a pair of parallel lines (
  • the main body 202 bifurcates into a leg 204 and a stem 206 which is used to attach a mating leg 208 to the main body 202.
  • the pair of legs 204 and 208 are typically designed to extend into the iliac arteries 106 and form a bifurcated distal portion which is often desirable for use with abdominal aortic aneurysms which extend into one or both of the iliac arteries 106.
  • Both the leg 204 and stem 206 may be defined by the stent system 214 and graft material 210. The invention is however not so limited.
  • the leg 204 may, for example, include a separate stent system, such as a simple metal spring interconnected to the stent system 214 by connecting bars, if desired.
  • the mating leg 208 typically includes a graft material 224 supported by a stent system 226. Similar to the main body 202, the leg 208 includes an expanded state (as shown) and may be deformed into a contracted state.
  • the stent system 226 and graft material 224 may, for example, be similar to that of the main body discussed above (e.g., a graft material supported by a honeycomb-shaped wire mesh). Alternatively, the form and/or material of the stent system 226 and graft material 224 can differ from that of the main body 202.
  • the stent system 226 may be made from a different material including, for example, nitinol which may be contracted to a contracted state and which springs to an expanded state without undergoing a phase change.
  • the stem 206 and mating leg 208 may be configured such that the leg 208 is advanced into the stem 206 and expanded within the stem 206 to retain the leg 208 in place.
  • the proximal end of the leg 208 may be flared.
  • Figures 3A-3C illustrate an exemplary stent-graft for bridging an abdominal aortic aneurysm in which the stent-graft is adapted to press against portions of the aortic wall above the renal and the superior mesenteric artery orifices and typically below the celiac axis orifice.
  • the example stent-graft 300 includes a main body 302 which bifurcates into a leg 304 and a stem 306 used to attach a mating leg 308 to the main body 302.
  • the main body 302, in this case, is adapted for supra-superior mesenteric fixation and is configured to expand against portions of the aortic wall 115 above the superior mesenteric artery 108.
  • the main body 302 of the stent-graft 300 includes a graft material 310 and a stent system 314 which define two renal apertures 312a and 312b each being alignable with a respective one of the renal arteries when the stent-graft 300 is expanded against the aortic wall 115 and a mesenteric aperture 314 which is oriented to align with the superior mesenteric artery 110 when the stent-graft 300 is expanded against the aortic wall 115.
  • the main body 302 may in general be constructed similar to the main body 202 discussed above.
  • the main body 302 may, for example, be formed from a shape memory alloy in a honeycomb shape having a number of interconnected wire loops, three of which form surrounding portions 318 which surround the renal apertures 312a and 312b and the mesenteric aperture 314.
  • the mesenteric aperture 314 is circumferentially located at an angle ⁇ (shown in Figure 3C) of about 50 to 75 degrees as measured from the center right renal aperture 312a and is longitudinally located a distance d2 (shown in Figure 3B) with respect to the right renal aperture 312a of about 1.0 to 1.5 cm.
  • shown in Figure 3C
  • d2 shown in Figure 3B
  • the use of a mesenteric aperture 314 which is larger than the mesenteric artery orifice provides tolerance by allowing for variable sizes and orientations of the mesenteric artery 110 relative to the renal arteries 112a and 112b.
  • the shape of the mesenteric aperture 314 can also vary and may, for example, be rectangular, circular, or ovular.
  • the mesenteric aperture 314 is ovular in shape and has a length in the longitudinal direction which is greater than a circumferential width. The length may range from about 1.8 to 2.0 cm and the width about 1.5 to 1.8 cm. In other embodiments, the mesenteric aperture 314 may have a length in the longitudinal direction which is less than a circumferential width.
  • Figures 4A-4C illustrate an exemplary stent-graft for bridging an abdominal aortic aneurysm in which the stent-graft is configured to be positioned against a portion of the aortic wall above the renal, superior mesenteric, and celiac axis artery orifices.
  • the example stent-graft 400 generally includes a main body 402 which bifurcates into a leg 404 and a stem 406 used to attach a mating leg 408 to the main body 402.
  • the main body 402 in this case, is adapted for supra-celiac axis fixation and is configured to expand against portions of the aortic wall 115 above celiac axis artery 110.
  • the main body 402 of the stent-graft 400 like the stent-graft 300 discussed above, includes a graft material 410 and a stent system 414 which define two renal apertures 412a and 412b each being alignable with a respective one of the renal arteries when the stent-graft 400 is expanded against the aortic wall 115 and a mesenteric aperture 414 which is oriented to align with the superior mesenteric artery 108 when the stent-graft 400 is expanded against the aortic wall 115.
  • the main body 402 further defines a celiac axis aperture 416 which is capable of aligning with the celiac axis artery 108 when the stent-graft 400 is expanded.
  • the main body 402 may in general be constructed similar to the main body 302 discussed above.
  • the renal apertures 412a and 412b as well as the mesenteric aperture 414 may, for example, be configured and oriented similar to the renal apertures 312a and 312b and mesenteric apertures 314 discussed above.
  • the characteristics of the celiac aperture 416 can vary. Typically, the celiac aperture 416 is larger than the orifice of the celiac axis artery. Suitable sizes of the celiac aperture 416 range from about 1.2 to 1.5 cm or more in diameter for many applications.
  • the orientation of the celiac aperture 416 relative to the other apertures can vary as well.
  • the celiac aperture 416 is circumferentially located at an angle ⁇ (shown in Figure 4C) of about 60 to 90 degrees as measured from the right renal aperture 412a. Longitudinally, the celiac aperture 416 is located a distance d 3 (shown in Figure 4B) with respect to the right renal aperture 412a of about 1.5 to 2.0 cm.
  • the shape of the celiac aperture 416 can vary.
  • the celiac aperture 416 is ovular in shape and has a length in the longitudinal direction which is greater than a circumferential width.
  • the length may range from about 1.8 to 2.0 cm and the width may range from about 1.5 to 1.8 cm in many applications.
  • the celiac aperture 416 may have a length in a longitudinal direction which is less than its width. While this embodiment illustrates the use of separate apertures for the celiac axis artery 108 and the superior mesenteric artery 110, in other embodiments, a single aperture may be formed to encompass both arteries 108 and 110.
  • stent-grafts shown in Figures 2-4 illustrate the use of bifurcated distal portions
  • the invention is however not limited to any particular distal portion configuration. What is important is that the proximal portion of the stent-graft include apertures capable of aligning with visceral artery orifices such that the stent- graft may be used to bridge aneurysms having minimal or no proximal neck.
  • Figure 5 and 6 illustrate two alternative distal portion configurations which may be used with the invention. These exemplary, alternative distal portion configurations are depicted with proximal portions designed for supra-celiac axis fixation. It is noted, however, that similar distal configurations may be used with each of the embodiments discussed above
  • a stent- graft 500 formed from a single body 502 configured to secure the proximal part of the stent-graft above the renal orifices and to secure the distal part of the stent-graft against a distal neck (e.g., between an aneurysm and the iliac bifurcation).
  • the exemplary body 502 includes a graft material 504 supported by a stent system 506 which runs the length of the graft material 504.
  • the body 502 may, for example, be constructed similar to those described above (e.g., DacronTM supported by a nitinol wire mesh).
  • the stent system 506 may differ from the stent systems above.
  • the stent system 506 may include a proximal stent system (e.g., nitinol wire mesh) supporting branch artery apertures and a distal stent system (e.g., a metal spring) connected to the proximal stent system through reinforcing bars.
  • Figure 6 illustrates a stent-graft 600 having bifurcated distal portion with two mating legs 606.
  • the stent-graft includes a main body 602 having two stems 604 for attaching the legs 606.
  • the main body 602 may be constructed similar to those described above with the exception of its lower end which includes the two stems 604 rather than a single stem and an attaching leg.
  • the mating legs may, for example, each be constructed similar to the mating leg 208 discussed above.
  • the stems 604 are typically sufficiently spaced from the lower aperture 612a to provide a segment 610 which may be used to retain part of the main body 602 within a sheath during deployment. Lengths of the segment 610 ranging, for example, from about 2 to 3 cm would be suitable for many applications.
  • aortic aneurysms having minimal or no necks can, for example, be excluded without obstructing blood flow through the renal arteries.
  • apertures having areas as large as or larger than the respective branch artery orifices positioning of the graft within an aorta is facilitated.
  • Figures 7A-7D illustrate an exemplary process for bridging an abdominal aortic aneurysm having minimal or no neck.
  • the exemplary process will be illustrated using a stent-graft similar to that depicted in Figure 4A-4C above.
  • a similar process may be employed to bridge abdominal aortic aneurysms using the other stent-grafts discussed above.
  • a main body 700 of the stent-graft is inserted within the vascular system 704 in a contracted state and typically over a guidewire 705.
  • Figure 7 A illustrates a view of the sheath 706 and main stent-graft body 700 within an iliac artery 712 as it is advanced toward the abdominal aortic aneurysm 710.
  • a balloon catheter is also disposed in the sheath 706 within the main stent-graft body 700. The balloon catheter will be used to partially expand the main stent-graft body 700 as will be discussed below.
  • the main stent-graft body 700 is then advanced to the abdominal aortic aneurysm 710, as illustrated in Figure 7B. This typically includes preliminarily positioning the sheathed main body 700 within the aorta 708 such that each aperture 702 approximately aligns with a respective one of the branch artery orifices 714-718.
  • the main stent-graft body 700 may be positioned within the aorta 708 in a variety of manners, using a number of different imaging techniques including, for example, single-plane or bi-plane fluoroscopy and/or three dimensional imaging.
  • radiopaque aperture markers and a radiopaque aligning system may be employed to axially and radially align the apertures 702 with the visceral orifices.
  • a radiopaque aligning system e.g., a 0-
  • an angiogram may first be developed to relate the visceral arteries to the spine or a radiopaque ruler. The alignment of the apertures 702 may then be related to the spine or ruler using the angiogram.
  • the main stent-graft body 700 may be viewed from desired angles to position the main body 700. While an aligning system would not be necessary, radiopaque aperture makers may be used to facilitate alignment using three-dimensional imaging.
  • a three- dimensional imaging program using computed tomography (CT) such as 3DVirtuoso from Siemens AG, Medical Engineering, Computed Tomography, Forchheim Germany, Vitrea, from Vital Images, Inc., Minneapolis, MN, or GENavigator from GE Medical Systems may be used.
  • CT computed tomography
  • FIG. 7C is a typical view of the main stent-graft body 700 when partially expanded.
  • the manner in which the main stent- graft body 700 is partially expanded varies with the shape-memory characteristics of stent system used.
  • partial expansion may, for example, be performed by withdrawing the sheath 706 to expose the apertures and expanding the exposed section of the main stent-graft body 700 using a water-cooled balloon which maintains the stent-graft at a temperature below the AF temperature.
  • the balloon by virtue of the cool water (illustrated by arrows 740) prevents the exposed section of the main stent-graft body 700 from fully expanding and, at the same time, forcibly expands the main stent-graft body 700 from its martensite shape.
  • Positioning and alignment of the main stent-graft body 700 while partially expanded may, for example, be performed using, for example, single or bi-plane fluoroscopy or three dimensional imaging as discussed above.
  • a lower section of the main stent-graft body 700 is kept within the sheath 706 to facilitate rotational alignment of the main stent-graft body 700 while partially expanded.
  • the main stent-graft body 700 is then expanded to its expanded state such that the apertures 702 align with the visceral artery orifices 714-718 and the main stent-graft body 700 presses against the aortic wall.
  • the main stent-graft body 700 may be expanded using a variety of techniques typically dependent on the shape memory characteristics of stent-graft used. With the a main stent-graft body having an AF temperature at or below body temperature, as discussed above, the main body 700 is typically expanded by withdrawing the cooled water and heating the stent system.
  • the stent system may, for example, be heated by the patient body itself and/or using external heating means (e.g., an electrical current).
  • a final inspection may be performed using, for example, fluoroscopy or three dimensional imaging, to insure proper location of the exposed part of the main stent-graft body 700.
  • the main stent-graft body 700 may be contracted and repositioning until proper positioning of the main stent-graft body 700 is achieved.
  • contraction of the main stent-graft body 700 may simply be accomplished by cooling the stent system (e.g., by flowing cool water through the balloon) below its MS temperature to suitably contract the main stent- graft body 700.
  • contraction may, for example, be accomplished by cooling and resheathing the exposed section of the main stent-graft body 700.
  • the exposed stent-graft section may be sheathed while cooling to insulate the patient's body from the effects of the cooling. Repositioning after contraction may be performed by as discussed above.
  • the main stent-graft body 700 presses against portions 724 and 726 of the aortic wall above the two renal artery orifices 714 (and in this case, above the superior mesenteric and celiac axis orifices 716 and 718) and the apertures 702 of the main stent-graft body 700 are positioned so that the branch artery orifices 714-718 typically lie within the apertures 702.
  • partial expansion of the main stent-graft body 700 can be performed by partially withdrawing the sheath 706 and heating the stent system to a temperature between its AS and AF temperatures, thereby partial expanding the stent system through partial recovery of its austenite form.
  • the heating may be performed using body heat alone or external means depending on the AS temperature of the stent system. For example, if the AS temperature is below body temperature, body heat alone may be used. If the AS temperature is above body temperature, some external heating is used.
  • a graft for bridging an abdominal aortic aneurysm can be efficiently positioned above the renal arteries (and if desired, above the celiac axis or superior mesenteric arteries) without obstructing the blood flow through the arteries.
  • the realignment of the apertures is particularly beneficial when aligning grafts having apertures for two or more vessels, such as grafts which have renal apertures and apertures for the mesenteric and/or celiac arteries.
  • Figure 8 is a flow chart illustrating an exemplary process for making a customized stent-graft for bridging a defect (e.g., an aneurysm) disposed in a main vessel near one or more branch vessels extending from the main vessel.
  • a three dimensional image of interior of the main vessel near the one or more branch vessels is developed prior to forming the stent- graft, as illustrated at block 802.
  • This typically involve using three dimensional imaging to reconstruct the interior portion of the main vessel, including the location and size of each of the one or more branch vessels.
  • Three dimensional reconstruction may by performed by exposing the relevant section of the main vessel and constructing a three dimensional image of the vessel section using the exposed images. This may be performed using, for example, a CT scanner and three dimensional imaging system, such as 3DVirtuoso, Vitea, or GENavigator.
  • a customized stent-graft is formed, as indicated in block 804.
  • the customized stent-graft generally includes one or more apertures each disposed on the stent-graft such that it aligns with a corresponding one or more of the branch vessels.
  • the customized stent-graft can be formed using the three-dimensional reconstruction using a number of different techniques. For example, the 3D reconstruction may be translated to a CAD program which in turn is used to manufacture the graft. This translation may, for example, be done using the CT-Modeller System from Materialise N.V., Belgium.
  • a stent-graft for bridging a defect such as an abdominal aortic aneurysm having minimal or no proximal neck
  • a defect such as an abdominal aortic aneurysm having minimal or no proximal neck
  • the apertures in stent-graft for renal arteries may be customizably formed in the graft material of the stent-graft using a three dimensional reconstruction of the interior of the aorta around the renal arteries (and in the optional cases the mesenteric and celiac arteries).
  • a customized stent-graft may be particularly advantageous when it is desired to bridge an abdominal aortic aneurysm of a patient having an abnormal aortic profile (e.g., abnormal size or orientation of branch vessels, more than two renal arteries, etc.).
  • an abnormal aortic profile e.g., abnormal size or orientation of branch vessels, more than two renal arteries, etc.
  • the present invention is generally directed to grafts for bridging defects in main vessels near one or more branch vessels.
  • the type of defect as well as the vessel in which the defect resides can vary. Accordingly, the present invention should not be considered limited to the particular examples described above, but rather should be understood to cover all aspects of the invention as fairly set out in the attached claims. Various modifications, equivalent processes, as well as numerous structures to which the conventional invention may be applicable will be readily apparent to those of skill in the art to which the present invention is directed upon review of the present specification. The claims are intended to cover such modifications and devices.

Abstract

An endovascular graft for bridging a defect in a main vessel near one or more branch vessels is provided. A graft, consistent with one embodiment of the invention, includes a tubular member which defines one or more apertures and is adapted for expansion against inner wall of a main vessel above one or more branch vessels. Each aperture defined by the tubular member is alignable with at least one of the one or more branch vessels and may have an area which is as large as or larger than the opening of the respective branch vessel(s) when the tubular member is expanded against the inner wall of the main vessel. Embodiments of the invention are particularly suited for bridging abdominal aortic aneurysms having short or no proximal necks, a significant factor limiting the use of conventional grafts for bridging abdominal aortic aneurysm.

Description

ENDOVASCULAR GRAFT FOR BRIDGING A DEFECT IN A MAIN VESSEL NEAR ONE OR MORE BRANCH VESSELS
Field of the Invention
The present invention generally relates to endovascular grafts and, more particularly, to a graft and process for bridging an abdominal aortic aneurysm disposed in the aorta near the renal arteries in which the graft is expanded against a portion of the aortic wall above one or both renal arteries.
Background of the Invention
Abdominal aortic aneurysms are potentially life threatening defects which generally lie in a section of the aorta between the renal arteries and the iliac arteries. In some cases, an abdominal aortic aneurysm may extend into either or both of the iliac arteries.
Abdominal aortic aneurysms are commonly treated using surgical techniques. Surgical treatment of abdominal aortic aneurysms is however a complicated procedure associated with high risk. As an alternative to surgery, a wide variety of grafts including, for example, stented grafts or stent-grafts, have been proposed for bridging and excluding abdominal aortic aneurysms. The use of these grafts is however limited. In most cases, an abdominal aortic aneurysm is either left untreated or is treated surgically. Even in cases using a graft, the procedure is sometimes terminated in favor of surgical treatment.
Summary of the Invention
The present invention generally provides grafts for bridging a main vessel having a defect disposed near one or more branch vessels extending from the main vessel. Embodiments of the invention are particularly suited for bridging abdominal aortic aneurysms having minimal or no proximal necks, a significant factor limiting the use of conventional grafts for bridging abdominal aortic aneurysms.
One particular embodiment of the invention provides a stent-graft for bridging an aneurysm in an aorta disposed below two renal arteries. The stent-graft includes a graft material defining two renal apertures each oriented to align with one of the two renal arteries when the stent-graft is in an expanded state. The stent-graft further includes a stent system for supporting the graft material in a contracted state wherein the renal apertures are contracted and the expanded state wherein the renal apertures are expanded. The stent system when in the expanded state, is adapted to press against a portion of the aortic wall above the first renal artery and against a portion of the aortic wall above the second renal artery. Each renal aperture may, for example, have an area as large as or larger than the opening of the respective renal artery.
In accordance with another embodiment of the invention, the graft material defines a mesenteric aperture oriented to align with a superior mesenteric artery when the stent-graft is in an expanded state. In accordance with yet another embodiment of the invention, the stent-graft material further defines a celiac aperture oriented to align with a celiac axis artery when the stent-graft is in the expanded state.
A graft, consistent with another embodiment of the invention, includes a tubular member which defines one or more apertures and is adapted for positioning against a wall of a main vessel above one or more branch vessels. Each aperture defined by the tubular member is alignable with at least one of the one or more branch vessels and has an area which is greater than the opening of the respective branch vessel(s) when the graft is positioned against the wall of the main vessel.
In accordance with another aspect of the invention, a process of bridging a defect disposed in a main vessel near one or more branch vessels is provided. Consistent with the process, a graft which defines one or more apertures is inserted in a contracted state within the main vessel. The graft is aligned within the main vessel such that each aperture aligns with at least a respective one of the branch vessels and expanded into a expanded state wherein the one or more apertures align with the one or more branch vessel and the graft presses against the main vessel wall. The process can, for example, be used to bridge an abdominal aortic aneurysm disposed in an aorta near the renal arteries.
In accordance with another aspect of the invention, a process for manufacturing a customized graft for bridging a defect disposed in a main vessel near one or more branch vessels is provided. The process includes developing a three dimensional image of an interior of the main vessel including the one or more branch vessels. Using the three dimensional image, a customized graft is formed having one or more apertures configured to align with the one or more branch vessels when the graft is positioned against the wall of the main vessel.
The above summary of the present invention is not intended to describe each illustrated embodiment or every implementation of the present invention. The figures and the detailed description which follow more particularly exemplify these embodiments.
Brief Description of the Drawings
The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:
Figure 1 illustrates a vascular section having an abdominal aortic aneurysm;
Figures 2A-2C illustrate an exemplary graft in accordance with one embodiment of the invention;
Figures 3A-3C illustrate an exemplary graft in accordance with another embodiment of the invention;
Figures 4A-4C illustrate an exemplary graft in accordance with another embodiment of the invention;
Figure 5 illustrates an exemplary graft in accordance with yet another embodiment of the invention;
Figure 6 illustrates an exemplary graft in accordance with still another embodiment of the invention;
Figures 7A-7D illustrate an exemplary process for deploying a graft in accordance with one embodiment of the invention;
Figure 8 is a flow chart illustrating an exemplary manufacturing process in accordance with an embodiment of the invention; and
Figure 9 illustrates a typical temperature vs. transformation curve for a shape memory alloy.
While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the appended claims.
Detailed Description of the Drawings
The present invention generally relates to endovascular grafts used for bridging a defect in a main vessel near one or more branch vessels. The invention is particularly suited for bridging and excluding abdominal aortic aneurysms located near the renal arteries. While the present invention is not so limited, an appreciation of various aspects of the invention will be gained through a discussion of the examples provided below.
The invention provides a graft for bridging a defect disposed in a main vessel near one or more branch vessels. The graft includes a tubular member which defines one or more apertures and is adapted for expansion against a portion of the main vessel wall above one or more branch vessels (i.e., against a portion of the main vessel wall opposite the defect). Each aperture defined by the end portion is alignable with at least one of the one or more branch vessels and typically has an area which is as large as or larger than the orifice of the respective branch vessel(s) when the tubular member is expanded against the inner wall of the main vessel. By way of example, in the discussion below, emphasis will be placed on grafts for bridging abdominal aortic aneurysms. However, the invention is not so limited. Other types of defects (e.g., pseudo-aneurysms and post-traumatic fistulas) which are located at the intersection of other body vessels (e.g., iliac bifurcation) are intended to be covered by the invention. Moreover, while the exemplary embodiments below illustrate the use of stented grafts, the invention is not limited thereto.
Figure 1 illustrates a front view of a exemplary vascular section 100 having a typical abdominal aortic aneurysm 102. The vascular section 100 includes an aorta 104 which bifurcates into two iliac arteries 106, a superior mesenteric artery 108, a celiac axis artery 110, and right and left renal arteries 112a and 112b, each of which branch off from the aorta 104. The renal arteries 112a and 112b may lie at the same or different levels and may be single or multiple in number. In the illustrated vascular section 100, the right renal artery 112a is shown below the left renal artery 112b. A more detailed discussion of the location of renal artery origins can be found in Verschuyl et al, "Renal Artery Origins: Location and Distribution in the Transverse Plane at CT," Radiology 1997, Vol. 203, pp. 71-75, April 1997.
The abdominal aortic aneurysm 102 generally lies in a section of the aorta 104 below the right and left renal arteries 112a and 112b and above the iliac arteries 106. In some cases, the aneurysm 102 may extend into either or both of the iliac arteries 106. As is typical of many abdominal aortic aneurysms, the illustrated aneurysm 102 has no proximal neck (e.g., the aneurysm extends up to and abuts the lower edges 114a and 114b of the right and/or left renal arteries 112a and 112b).
Conventional grafts used to bridge abdominal aortic aneurysms typically have a proximal end designed for positioning against a proximal neck, i.e., a patent portion of the aortic wall below the renal arteries 112a and 112b. Typically, necks greater than 10 millimeters (mm) are needed to reliably secure a conventional graft. With, necks less than 5 mm conventional grafts typically cannot be reliably secured. One conventional graft which attempts to address the problems associated with minimal proximal necks includes a webbed end which may be positioned slightly over the lower edge 114a of the right renal artery 112a. This graft however still requires some neck in order to adequately seal the proximal end of the graft and sufficiently retain the graft within the aorta. Moreover, the webbed end can partially obstruct flow through the lower renal artery 112a. The present invention overcomes the limitations of conventional grafts and provides an endovascular graft and process for bridging abdominal aortic aneurysms having minimal (e.g., less than 5 or 10 mm) or no proximal necks.
Figures 2A-2C illustrate an exemplary stent-graft for bridging an abdominal aortic aneurysm in accordance with an embodiment of the invention. By way of example and not of limitation, reference will be made to the exemplary vascular section 100 discussed above to facilitate understanding of the stent-graft 200. As shown in Figure 2A, the stent-graft 200 includes a main body 202 which bifurcates into a leg 204 and a stem 206, the latter of which is used to attach a mating leg 208 to the main body 202. The main body 202 of the stent-graft 200 is advantageously adapted for supra-renal fixation. In particular, the main body 202 is configured to expand against portions 116 and 118 of the aortic wall 115 above the renal arteries 112a and 112b. The term above is used herein to describe a vessel wall portion on a side of a branch vessel opposite the side of the branch vessel where a defect lies.
The main body 202 of the stent-graft 200 includes a graft material 210 and a stent system 214 (shown in dashed lines) which supports the graft material 210. The stent system 214 typically has an expanded state for securing the main body 202 within the aorta 104 and is deformable into a contracted state for insertion through the vascular system of a patient. In its expanded state, the stent system 214 typically exerts sufficient force against the aortic wall to retain the main body 202 in place and form a blood-tight seal between the main body 202 and the aortic wall. The main body 202 is shown with the stent system 214 in the expanded state. In its contracted state, the stent system 214 (and main body 202) may take a variety of different forms. In its expanded state, the main body 202 is configured to expand against portions 116 and 118 of the aortic wall 115 above the renal arteries 112a and 112b.
The graft material 210 is typically distensible such that the graft material 210 can adapt to the stent system 214 when the main body 202 is contracted and expanded. The graft material 210 may be formed from a number of different well- known materials, such as Dacron™, Gortex™, polyethylene or polyurethane, for example. The graft material 210 may be secured to the stent system 214 using, for example, well-known stitching, gluing or weaving techniques. While the invention is not so limited, the stent system may be disposed on the exterior or interior of the graft material 210, or within the graft material 210 itself.
The graft material 210 generally defines two renal apertures 212a and 212b each of which are alignable with a respective one of the renal arteries 112a and 112b when the main body 202 is expanded against the aortic wall. The shapes, sizes and relative orientation of the renal apertures 212a and 212b can vary as will be discussed below. The renal apertures 212a and 212b are each typically supported by a surrounding portion 218 of the stent system 214. The surrounding portions 218 of the stent system 214 may be shaped similar to and completely surround the perimeters of the renal apertures 212a and 212b. The renal apertures 212a and 212b may be supported by the surrounding portions 218 of the stent system 214 by, for example, stitching portions of the graft material 210 around the apertures 212a and 212b to the surrounding stent portions. By supporting the perimeter of each aperture with the stent system 214, a tight seal can be formed between the graft material 210 and the aortic wall 115 around the renal artery orifices and leakage can be prevented. While the invention is not so limited, the exemplary stent system 214 is formed of a wire (e.g., nitinol) mesh in a honeycomb pattern having a number of interconnected wire loops, two of the which form surrounding portions 218 and align with the renal apertures 212a and 212b in the graft material 210. The proximal end 220 of the stent system 214 generally seals the main body 202 against the aortic wall 115, and may, for example, include a wire portion 222 interconnecting loops of stent system 214.
The stent system 214 may be formed of a number of different materials including, for example, metals and/or metal alloys. In one embodiment, the stent system 214 is formed from a shape-memory alloy (SMA), such as nitinol. Shape- memory alloys have the ability to transform from a martensite phase shape (in which the stent system 214 may be deformed to a contracted state) to a parent or austenite phase (typically corresponding to the expanded state of the stent system 214). An SMA may exhibit either one-way or two-way shape memory. With two-way shape memory, the SMA changes shape upon both heating and cooling. With one-way shape memory, the SMA undergoes shape change only upon heating. Upon cooling, the shape of the SMA does not spontaneously change, but may be changed by force.
Turning to Figure 9, there is illustrated a typical transformation vs. temperature curve for an SMA specimen. The curve 900 typically includes a heating curve 910, on which the SMA specimen generally undergoes transformation from a martensite phase 912 to an austenite phase 914, and a cooling curve 930 on which the phase change is reversed. While the phase transformations take place over a relatively broad temperature range, the majority of phase transformation typically occurs over a relatively narrow temperature band. The austenite start and finish (AS and AF) temperatures generally denote temperatures between which the majority of the martensite-to-austenite transformation on the heating curve 910 occurs. The martensite start and finish (MS and MF) temperature denote similar temperatures on the cooling curve 930. As can be seen, the transformation curve 900 exhibits hysteris T, (i.e., an offset between the heating and cooling curves 910 and 930). In one particular embodiment of the invention, the stent system 214 is formed from an SMA, such as nitinol, having a AF temperature of about body temperature or less (typically 37°C or less). This enables the stent system 214 to transform into its parent or austenite phase (typically corresponding to the expanded state of the stent system 214) when subject to body temperature. In another embodiment, the stent system 214 is formed from an SMA, such as nitinol, having an AF temperature greater than body temperature (e.g., an AF temperature of about 48°C). This enables the stent system 214 to be partially expanded to an intermediate state when between an AS temperature (e.g., 35°C) and the AF temperature and also allows the stent system 214 to be fully expanded when heated above the AF temperature. In the latter embodiment, the MS temperature of the stent system 214 is typically selected to be below body temperature (e.g., about 20°C) to prevent partial matertensite transformation when the stent system 214 returns to body temperature. In either embodiment, the stent system 214 may demonstrate one-way or two-way shape change.
Referring back to Figures 2A-2C, details of the renal apertures 212a and 212b will be discussed. As noted above, the renal apertures 212a and 212b are located on the main body 202 such that, when expanded, the renal apertures 212a and 212b align with the renal artery orifices of a patient. The size of each renal aperture 212a and 212b is typically selected to be at least as large as the orifice of its respective renal artery 112a and 112b. The size of each renal aperture 212a and 212b can vary as the sizes of renal arteries can vary from patient to patient. Suitable sizes of the renal apertures 212a and 212b range from about 0.8 to 1.0 cm or more in diameter for many applications. The use of renal apertures 212a and 212b which are larger than the renal artery orifices allows for variable position of the renal arteries from patient to patient and by allowing some tolerance in the deployment of the main body 202 of the stent-graft 200.
The shape of the apertures 212a and 212b can also vary and may, for example, be rectangular, circular, or ovular. In the example embodiment, each aperture 212a and 212b is ovular in shape and has a length in the longitudinal direction which is greater than a circumferential width. For example, the length may be about 1.2 to 1.5 cm and the width about 1.0 to 1.2 cm. In other embodiments, each aperture 212a and 212b may have a length in the longitudinal direction which is less than a circumferential width. Moreover, the two renal apertures 212a and 212b may have different shapes and/or sizes. For example, one may be oval-shaped and extended in the longitudinal direction, while the other may be oval-shaped and extended in the circumferential direction. As should be appreciated, stent system 214 can be designed to accommodate various shapes of the apertures 212a and 212b.
The relative orientation of the renal apertures 212a and 212b can vary as well. To illustrate exemplary orientations, the angle θ (shown in Figure 2C) will be used to define the angular distance between the centers of the apertures 212a and 212b and the distance dj (shown in Figure 2B) will be used to define the distance between the centers of the apertures 212a and 212b along the longitudinal axis of the stent-graft 200. Relative orientations having an angle θ ranging between about 72 to 225 degrees, and more typically between about 140 and 185 degrees, and a distance d ranging from about 0 to 2 cm would be suitable for many applications.
Highly radiopaque markers may be placed on the main body 202 to facilitate identification of the main body 202 within the aorta 103. Advantageously, radiopaque markers may be positioned near or around each renal aperture 212a and 212b to improve visualization and facilitate alignment of the apertures 212a and 212b. This may be done by, for example, soldering radiopaque material (e.g., gold or platinum) to the portions 218 of the stent system 214 surrounding the apertures 212a and 212b. In addition, a radiopaque aligning system may also be placed on the stent-graft portion 210 to aid in aligning the main body 202 with a desired plane, such as the anterior-posterior or A-P plane. For example, a radiopaque diamond (0) may be placed on one side of the main body 202 and a radiopaque vertical line (|) on the opposite side such that when the diamond (0) aligns with the line (|), the stent- graft portion 210 is aligned with the desired plane. A diamond (0) - vertical line (|) aligning system is illustrated in Figure 2A. A number of other arrangements, such a pair of parallel lines (||) and a perpendicular line (-) or an X and an O, may be used as well.
As noted above, the main body 202 bifurcates into a leg 204 and a stem 206 which is used to attach a mating leg 208 to the main body 202. While not shown to scale, the pair of legs 204 and 208 are typically designed to extend into the iliac arteries 106 and form a bifurcated distal portion which is often desirable for use with abdominal aortic aneurysms which extend into one or both of the iliac arteries 106. Both the leg 204 and stem 206 may be defined by the stent system 214 and graft material 210. The invention is however not so limited. The leg 204 may, for example, include a separate stent system, such as a simple metal spring interconnected to the stent system 214 by connecting bars, if desired.
The mating leg 208 typically includes a graft material 224 supported by a stent system 226. Similar to the main body 202, the leg 208 includes an expanded state (as shown) and may be deformed into a contracted state. The stent system 226 and graft material 224 may, for example, be similar to that of the main body discussed above (e.g., a graft material supported by a honeycomb-shaped wire mesh). Alternatively, the form and/or material of the stent system 226 and graft material 224 can differ from that of the main body 202. For example, the stent system 226 may be made from a different material including, for example, nitinol which may be contracted to a contracted state and which springs to an expanded state without undergoing a phase change. The stem 206 and mating leg 208 may be configured such that the leg 208 is advanced into the stem 206 and expanded within the stem 206 to retain the leg 208 in place. To facilitate retention within the stem 206, the proximal end of the leg 208 may be flared.
Figures 3A-3C illustrate an exemplary stent-graft for bridging an abdominal aortic aneurysm in which the stent-graft is adapted to press against portions of the aortic wall above the renal and the superior mesenteric artery orifices and typically below the celiac axis orifice. The example stent-graft 300 includes a main body 302 which bifurcates into a leg 304 and a stem 306 used to attach a mating leg 308 to the main body 302. The main body 302, in this case, is adapted for supra-superior mesenteric fixation and is configured to expand against portions of the aortic wall 115 above the superior mesenteric artery 108.
The main body 302 of the stent-graft 300 includes a graft material 310 and a stent system 314 which define two renal apertures 312a and 312b each being alignable with a respective one of the renal arteries when the stent-graft 300 is expanded against the aortic wall 115 and a mesenteric aperture 314 which is oriented to align with the superior mesenteric artery 110 when the stent-graft 300 is expanded against the aortic wall 115.
With the exception of its length (which is longer to accommodate the mesenteric aperture 314), the main body 302 may in general be constructed similar to the main body 202 discussed above. For example, the main body 302 may, for example, be formed from a shape memory alloy in a honeycomb shape having a number of interconnected wire loops, three of which form surrounding portions 318 which surround the renal apertures 312a and 312b and the mesenteric aperture 314.
The renal apertures 312a and 312b may, for example, be configured and oriented similar to the renal apertures 212a and 212b discussed above. The characteristics of the mesenteric aperture 314 can vary. Typically, the mesenteric aperture 314 is as large as or larger than the orifice of the mesenteric artery. Suitable sizes of the mesenteric aperture 314 range from about 1.2 to 1.5 cm or more in diameter for many applications. The orientation of the mesenteric aperture 314 relative to the renal apertures 312a and 312b can vary. Typically, the mesenteric aperture 314 is circumferentially located at an angle α (shown in Figure 3C) of about 50 to 75 degrees as measured from the center right renal aperture 312a and is longitudinally located a distance d2 (shown in Figure 3B) with respect to the right renal aperture 312a of about 1.0 to 1.5 cm. The use of a mesenteric aperture 314 which is larger than the mesenteric artery orifice provides tolerance by allowing for variable sizes and orientations of the mesenteric artery 110 relative to the renal arteries 112a and 112b.
The shape of the mesenteric aperture 314 can also vary and may, for example, be rectangular, circular, or ovular. In the example embodiment, the mesenteric aperture 314 is ovular in shape and has a length in the longitudinal direction which is greater than a circumferential width. The length may range from about 1.8 to 2.0 cm and the width about 1.5 to 1.8 cm. In other embodiments, the mesenteric aperture 314 may have a length in the longitudinal direction which is less than a circumferential width.
Figures 4A-4C illustrate an exemplary stent-graft for bridging an abdominal aortic aneurysm in which the stent-graft is configured to be positioned against a portion of the aortic wall above the renal, superior mesenteric, and celiac axis artery orifices. The example stent-graft 400 generally includes a main body 402 which bifurcates into a leg 404 and a stem 406 used to attach a mating leg 408 to the main body 402. The main body 402, in this case, is adapted for supra-celiac axis fixation and is configured to expand against portions of the aortic wall 115 above celiac axis artery 110.
The main body 402 of the stent-graft 400, like the stent-graft 300 discussed above, includes a graft material 410 and a stent system 414 which define two renal apertures 412a and 412b each being alignable with a respective one of the renal arteries when the stent-graft 400 is expanded against the aortic wall 115 and a mesenteric aperture 414 which is oriented to align with the superior mesenteric artery 108 when the stent-graft 400 is expanded against the aortic wall 115. In this case, the main body 402 further defines a celiac axis aperture 416 which is capable of aligning with the celiac axis artery 108 when the stent-graft 400 is expanded. With the exception of its length (which is longer to accommodate the celiac axis aperture 416), the main body 402 may in general be constructed similar to the main body 302 discussed above.
The renal apertures 412a and 412b as well as the mesenteric aperture 414 may, for example, be configured and oriented similar to the renal apertures 312a and 312b and mesenteric apertures 314 discussed above. The characteristics of the celiac aperture 416 can vary. Typically, the celiac aperture 416 is larger than the orifice of the celiac axis artery. Suitable sizes of the celiac aperture 416 range from about 1.2 to 1.5 cm or more in diameter for many applications. The orientation of the celiac aperture 416 relative to the other apertures can vary as well. Typically, the celiac aperture 416 is circumferentially located at an angle γ (shown in Figure 4C) of about 60 to 90 degrees as measured from the right renal aperture 412a. Longitudinally, the celiac aperture 416 is located a distance d3 (shown in Figure 4B) with respect to the right renal aperture 412a of about 1.5 to 2.0 cm.
Like the apertures above, the shape of the celiac aperture 416 can vary. In the example embodiment, the celiac aperture 416 is ovular in shape and has a length in the longitudinal direction which is greater than a circumferential width. For example, the length may range from about 1.8 to 2.0 cm and the width may range from about 1.5 to 1.8 cm in many applications. In other embodiments, the celiac aperture 416 may have a length in a longitudinal direction which is less than its width. While this embodiment illustrates the use of separate apertures for the celiac axis artery 108 and the superior mesenteric artery 110, in other embodiments, a single aperture may be formed to encompass both arteries 108 and 110.
While the above embodiments illustrate stent-grafts having at least two apertures (e.g., for the renal arteries), the invention is not so limited. Stent-grafts having only one aperture for bridging a defect (e.g., an aneurysm) may be formed having proximal end portions configured to be positioned against a portion of a main vessel wall above only one branch artery. Single aperture stent-grafts may be used in a variety of circumstances including, for example, bridging abdominal aortic aneurysms where the right and left renal arteries are sufficiently offset to allow the use of one renal aperture without blocking the other artery. Moreover, while the example stent-grafts shown in Figures 2-4 illustrate the use of bifurcated distal portions, the invention is however not limited to any particular distal portion configuration. What is important is that the proximal portion of the stent-graft include apertures capable of aligning with visceral artery orifices such that the stent- graft may be used to bridge aneurysms having minimal or no proximal neck.
Figure 5 and 6 illustrate two alternative distal portion configurations which may be used with the invention. These exemplary, alternative distal portion configurations are depicted with proximal portions designed for supra-celiac axis fixation. It is noted, however, that similar distal configurations may be used with each of the embodiments discussed above In Figure 5, there is illustrated a stent- graft 500 formed from a single body 502 configured to secure the proximal part of the stent-graft above the renal orifices and to secure the distal part of the stent-graft against a distal neck (e.g., between an aneurysm and the iliac bifurcation). The exemplary body 502 includes a graft material 504 supported by a stent system 506 which runs the length of the graft material 504. The body 502 may, for example, be constructed similar to those described above (e.g., Dacron™ supported by a nitinol wire mesh). Alternatively, the stent system 506 may differ from the stent systems above. For instance, the stent system 506 may include a proximal stent system (e.g., nitinol wire mesh) supporting branch artery apertures and a distal stent system (e.g., a metal spring) connected to the proximal stent system through reinforcing bars. Figure 6 illustrates a stent-graft 600 having bifurcated distal portion with two mating legs 606. The stent-graft includes a main body 602 having two stems 604 for attaching the legs 606. The main body 602 may be constructed similar to those described above with the exception of its lower end which includes the two stems 604 rather than a single stem and an attaching leg. The mating legs may, for example, each be constructed similar to the mating leg 208 discussed above. In the this embodiment, the stems 604 are typically sufficiently spaced from the lower aperture 612a to provide a segment 610 which may be used to retain part of the main body 602 within a sheath during deployment. Lengths of the segment 610 ranging, for example, from about 2 to 3 cm would be suitable for many applications.
Using the above grafts, defects such as abdominal aortic aneurysms may be more effectively bridged than compared to conventional techniques. In particular, by providing a graft which can be disposed against portions of the aortic wall above the renal arteries (and, if desired, above the superior mesenteric or celiac axis arteries), aortic aneurysms having minimal or no necks can, for example, be excluded without obstructing blood flow through the renal arteries. Additionally, by providing apertures having areas as large as or larger than the respective branch artery orifices, positioning of the graft within an aorta is facilitated.
It is stressed that the sizes, shapes and orientations of the various apertures discussed in the embodiments above are provided by way of example only and are not intended to limit the scope of the invention. Indeed, it is contemplated that a number of different grafts having apertures of different sizes, shapes and/or orientations will be made in order to accommodate variations in the size, shape and location of the renal, superior mesenteric and/or celiac axis orifices of different patients.
Figures 7A-7D illustrate an exemplary process for bridging an abdominal aortic aneurysm having minimal or no neck. By way of example and not of limitation, the exemplary process will be illustrated using a stent-graft similar to that depicted in Figure 4A-4C above. A similar process may be employed to bridge abdominal aortic aneurysms using the other stent-grafts discussed above.
Consistent with the exemplary process, a main body 700 of the stent-graft is inserted within the vascular system 704 in a contracted state and typically over a guidewire 705. This typically involves placing the main stent-graft body 700 within a sheath 706, introducing the sheath 706 and the main body 700 into the vascular system 704 at an access site (not shown) and advancing the sheath 706 and main body 700 through the vascular system 704 toward the abdominal aortic aneurysm 710. Figure 7 A illustrates a view of the sheath 706 and main stent-graft body 700 within an iliac artery 712 as it is advanced toward the abdominal aortic aneurysm 710. In the example embodiment, a balloon catheter is also disposed in the sheath 706 within the main stent-graft body 700. The balloon catheter will be used to partially expand the main stent-graft body 700 as will be discussed below.
Optionally, prior to initial deployment of the main stent-graft body 700, the various visceral artery orifices may be marked to facilitate alignment of the main body 700 with the orifices. Marking of the renal orifices may be performed by, for example, placing a 0.014 to 0.018 inch platinum tip guide wire into each of the visceral arteries using well-known techniques.
The main stent-graft body 700 is then advanced to the abdominal aortic aneurysm 710, as illustrated in Figure 7B. This typically includes preliminarily positioning the sheathed main body 700 within the aorta 708 such that each aperture 702 approximately aligns with a respective one of the branch artery orifices 714-718. The main stent-graft body 700 may be positioned within the aorta 708 in a variety of manners, using a number of different imaging techniques including, for example, single-plane or bi-plane fluoroscopy and/or three dimensional imaging.
Using fluoroscopy, for example, radiopaque aperture markers and a radiopaque aligning system (e.g., a 0-| aligning system) may be employed to axially and radially align the apertures 702 with the visceral orifices. Using this technique, an angiogram may first be developed to relate the visceral arteries to the spine or a radiopaque ruler. The alignment of the apertures 702 may then be related to the spine or ruler using the angiogram.
Using three-dimensional imaging, the main stent-graft body 700 may be viewed from desired angles to position the main body 700. While an aligning system would not be necessary, radiopaque aperture makers may be used to facilitate alignment using three-dimensional imaging. With this technique, a three- dimensional imaging program using computed tomography (CT), such as 3DVirtuoso from Siemens AG, Medical Engineering, Computed Tomography, Forchheim Germany, Vitrea, from Vital Images, Inc., Minneapolis, MN, or GENavigator from GE Medical Systems may be used.
The main stent-graft body 700 is then partially expanded and the positioning of the main stent-graft body 700 is adjusted, if needed, in order to align the apertures 702 with the branch artery orifices 714-718. Figure 7C is a typical view of the main stent-graft body 700 when partially expanded. The manner in which the main stent- graft body 700 is partially expanded varies with the shape-memory characteristics of stent system used. For instance, using a main stent-graft body 700 having a stent- system with an AF temperature at or below body temperature, partial expansion may, for example, be performed by withdrawing the sheath 706 to expose the apertures and expanding the exposed section of the main stent-graft body 700 using a water-cooled balloon which maintains the stent-graft at a temperature below the AF temperature. In this manner, the balloon by virtue of the cool water (illustrated by arrows 740) prevents the exposed section of the main stent-graft body 700 from fully expanding and, at the same time, forcibly expands the main stent-graft body 700 from its martensite shape.
Positioning and alignment of the main stent-graft body 700 while partially expanded may, for example, be performed using, for example, single or bi-plane fluoroscopy or three dimensional imaging as discussed above. Advantageously, a lower section of the main stent-graft body 700 is kept within the sheath 706 to facilitate rotational alignment of the main stent-graft body 700 while partially expanded.
The main stent-graft body 700 is then expanded to its expanded state such that the apertures 702 align with the visceral artery orifices 714-718 and the main stent-graft body 700 presses against the aortic wall. The main stent-graft body 700 may be expanded using a variety of techniques typically dependent on the shape memory characteristics of stent-graft used. With the a main stent-graft body having an AF temperature at or below body temperature, as discussed above, the main body 700 is typically expanded by withdrawing the cooled water and heating the stent system. The stent system may, for example, be heated by the patient body itself and/or using external heating means (e.g., an electrical current). After expanding the exposed section of main stent-graft body 700 against the aortic wall, a final inspection may be performed using, for example, fluoroscopy or three dimensional imaging, to insure proper location of the exposed part of the main stent-graft body 700. Should the main stent-graft body 700 need repositioning, the main stent-graft body 700 may be contracted and repositioning until proper positioning of the main stent-graft body 700 is achieved. For example, using a two- way shape memory stent system, contraction of the main stent-graft body 700 may simply be accomplished by cooling the stent system (e.g., by flowing cool water through the balloon) below its MS temperature to suitably contract the main stent- graft body 700. Using a one-way, shape memory stent system, contraction may, for example, be accomplished by cooling and resheathing the exposed section of the main stent-graft body 700. In both cases, the exposed stent-graft section may be sheathed while cooling to insulate the patient's body from the effects of the cooling. Repositioning after contraction may be performed by as discussed above.
Once the exposed section of the main stent-graft body 700 is properly positioned, the remaining, sheathed section of the main stent-graft body 700 is then exposed and fully expanded, for example, by body heat and/or external heating means. The mating leg 730 then attached to the main body 700 of the stent graft. Typically, this includes sheathing the leg and advancing the sheathed leg into a stem 732 of the main body 700. The sheath is then withdrawn and the leg 730 expanded against the stem 732 for retention. Figure 7D illustrates a typical position of the stent-graft after full deployment. In particular, the main stent-graft body 700 presses against portions 724 and 726 of the aortic wall above the two renal artery orifices 714 (and in this case, above the superior mesenteric and celiac axis orifices 716 and 718) and the apertures 702 of the main stent-graft body 700 are positioned so that the branch artery orifices 714-718 typically lie within the apertures 702. Advantageously, the proximal end 722 of the main stent-graft body 700 sealingly engages the aortic wall without need of an aneurysm neck (i.e., patent portions of the aortic wall between the renal artery orifices 714 and the aneurysm 710), while portions of the stent system surrounding the apertures 702 provide adequate sealing around the branch artery orifices 714-718. As noted above, partial expansion and full expansion of the main stent-graft body 700 can vary with the type of stent system used. Using, for example, a main stent-graft body 700 having a stent-system with an AF temperature greater than body temperature (e.g. about 48°C), partial expansion of the main stent-graft body 700 can be performed by partially withdrawing the sheath 706 and heating the stent system to a temperature between its AS and AF temperatures, thereby partial expanding the stent system through partial recovery of its austenite form. The heating may be performed using body heat alone or external means depending on the AS temperature of the stent system. For example, if the AS temperature is below body temperature, body heat alone may be used. If the AS temperature is above body temperature, some external heating is used.
The main stent-graft body 700 may then be fully expanded to its expanded state by heating the stent-graft through its AF temperature. This may, for example, be done using, for example, known external heating means. In this case, it is noted that the temperature of the main stent-graft body 700 will retreat to body temperature after removal of the external heat. However, the main stent-graft body 700 can remain in its expanded (e.g., austenite ) state rather than transform to a contracted (e.g., martensite) state due to, for example, transformation hysteris.
Using the above process, a graft for bridging an abdominal aortic aneurysm can be efficiently positioned above the renal arteries (and if desired, above the celiac axis or superior mesenteric arteries) without obstructing the blood flow through the arteries. The realignment of the apertures is particularly beneficial when aligning grafts having apertures for two or more vessels, such as grafts which have renal apertures and apertures for the mesenteric and/or celiac arteries.
Figure 8 is a flow chart illustrating an exemplary process for making a customized stent-graft for bridging a defect (e.g., an aneurysm) disposed in a main vessel near one or more branch vessels extending from the main vessel. In accordance with this process, a three dimensional image of interior of the main vessel near the one or more branch vessels is developed prior to forming the stent- graft, as illustrated at block 802. This typically involve using three dimensional imaging to reconstruct the interior portion of the main vessel, including the location and size of each of the one or more branch vessels. Three dimensional reconstruction may by performed by exposing the relevant section of the main vessel and constructing a three dimensional image of the vessel section using the exposed images. This may be performed using, for example, a CT scanner and three dimensional imaging system, such as 3DVirtuoso, Vitea, or GENavigator.
Using the three dimensional image, a customized stent-graft is formed, as indicated in block 804. The customized stent-graft generally includes one or more apertures each disposed on the stent-graft such that it aligns with a corresponding one or more of the branch vessels. The customized stent-graft can be formed using the three-dimensional reconstruction using a number of different techniques. For example, the 3D reconstruction may be translated to a CAD program which in turn is used to manufacture the graft. This translation may, for example, be done using the CT-Modeller System from Materialise N.V., Belgium.
Using the above process, a stent-graft for bridging a defect, such as an abdominal aortic aneurysm having minimal or no proximal neck, may be customized to the patient. In particular, the apertures in stent-graft for renal arteries (and if desired, apertures for the mesenteric and/or celiac arteries) may be customizably formed in the graft material of the stent-graft using a three dimensional reconstruction of the interior of the aorta around the renal arteries (and in the optional cases the mesenteric and celiac arteries). A customized stent-graft may be particularly advantageous when it is desired to bridge an abdominal aortic aneurysm of a patient having an abnormal aortic profile (e.g., abnormal size or orientation of branch vessels, more than two renal arteries, etc.).
As noted above, the present invention is generally directed to grafts for bridging defects in main vessels near one or more branch vessels. The type of defect as well as the vessel in which the defect resides can vary. Accordingly, the present invention should not be considered limited to the particular examples described above, but rather should be understood to cover all aspects of the invention as fairly set out in the attached claims. Various modifications, equivalent processes, as well as numerous structures to which the conventional invention may be applicable will be readily apparent to those of skill in the art to which the present invention is directed upon review of the present specification. The claims are intended to cover such modifications and devices.

Claims

What is claimed is:
1. A stent-graft for bridging an aneurysm in an aorta, the aneurysm being at least partially disposed between two renal arteries and two iliac arteries, comprising: a graft material defining two renal apertures each oriented to align with one of the two renal arteries when the stent-graft is in an expanded state; and a stent system for supporting the graft material in a contracted state wherein each renal aperture is contracted and the expanded state wherein each renal aperture is expanded.
2. The stent-graft of claim 1 , wherein each renal aperture is substantially oval.
3. The stent-graft of claim 1 , wherein each renal aperture is at least as large as the orifice of the respective renal artery.
4. The stent-graft of claim 1 , wherein the two renal apertures are circumferentially separated by about 140 to 185 degrees.
5. The stent-graft of claim 1 , wherein the two renal apertures are longitudinally separated by about 0 to 2 cm.
6. The stent-graft of claim 1 , wherein the stent system, when in the expanded state, is adapted to press against a portion of the aortic wall above the first renal artery and against a portion of the aortic wall above the second renal artery.
7. The stent-graft of claim 6, wherein the graft material defines a mesenteric aperture oriented to align with a superior mesenteric artery when the stent-graft is in an expanded state.
8. The stent-graft of claim 7, wherein the stent system supports the mesenteric aperture and when in the expanded state, is adapted to press against a portion of the aortic wall above the superior mesenteric artery.
9. The stent-graft of claim 8, wherein the graft material defines a celiac aperture oriented to align with a celiac axis artery when the stent-graft is in the expanded state.
10. The stent-graft of claim 9, wherein the stent system supports the celiac aperture and when in the expanded state, is adapted to press against a portion of the inner wall of the aorta above the celiac axis artery.
11. The graft of claim 1. wherein the stent system is formed from a shape memory alloy.
12. The graft of claim 11 , wherein the shape memory alloy exhibits two-way shape change.
13. The graft of claim 11 , wherein the shape memory alloy exhibits one-way shape change.
14. The graft of claim 1 , wherein the stent-graft further includes at least one stem and a leg attachable to the stem.
15. The graft of claim 1, where the stent-graft includes two stems and two legs, each leg being attachable to one of the stems.
16. A graft for bridging a defect in a main vessel disposed near one or more branch vessels extending from the main vessel, comprising: a tubular member adapted for positioning against a wall of the main vessel above the one or more branch vessels; and one or more apertures defined by the tubular member, each of the one or more apertures being alignable with at least one of the one or more branch vessels and having an area greater than the opening of the respective at least one branch vessel when the tubular member is positioned against the wall of the main vessel.
17. The graft of claim 16, wherein the tubular member is adapted for positioning against the inner wall of the main vessel above one or more second branch vessels, the tubular member defining one or more second apertures each alignable with one of the second branch vessels.
18. The graft of claim 16, wherein the tubular member includes a graft material defining the one or more aperture and a stent system supporting the graft material, wherein the stent system includes one or more supporting portions each surrounding at least part of the perimeter of at least one of the one or more apertures.
19. A process of bridging a defect disposed in a main vessel near one or more branch vessels, comprising: inserting, within the main vessel, a graft in a contracted state, the graft defining one or more apertures; aligning the graft within the main vessel such that each aperture aligns with at least a respective one of the branch vessels; and expanding the graft to an expanded state wherein the one or more apertures are aligned with the one or more branch vessels and the graft presses against a wall of the main vessel.
20. The process of claim 19, wherein aligning the graft includes partially expanding the graft and aligning the graft while partially expanded.
21. The process of claim 20, wherein partially expanding the graft includes maintaining the graft in at least a partial martensite phase while forcibly expanding the graft.
22. The process of claim 20, wherein partially expanding the graft includes heating the stent to a temperature between an austenite start temperature and an austenite finish temperature of the graft.
23. A process of manufacturing a graft for bridging a defect in a main vessel, the defect being disposed in the main vessel near one or more branch vessels extending from the main vessel, the process comprising: developing a three dimensional image of an interior of the main vessel including the one or more branch vessels prior to inserting the graft in the main vessel; and using the three dimensional image to form one or more apertures in the graft prior to inserting the graft within the main vessel, each aperture configured to align with a respective one of the one or more branch vessels.
24. A graft for bridging a defect disposed in a main vessel near a branch vessel extending from the main vessel, the branch vessel being disposed between a first side of the main vessel in which the defect is disposed and a second side of the main vessel opposite the first side, the graft comprising: a tubular member adapted for positioning against a wall portion of the main vessel on the second side of the main vessel opposite the defect; and one or more apertures defined by the tubular member, each of the one or more apertures being alignable with at least one of the one or more branch vessels and having an area greater than the opening of the respective at least one branch vessel when the tubular member is positioned against the wall of the main vessel.
PCT/US1999/002704 1998-02-09 1999-02-09 Endovascular graft for bridging a defect in a main vessel near one or more branch vessels WO1999039663A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU25928/99A AU2592899A (en) 1998-02-09 1999-02-09 Endovascular graft for bridging a defect in a main vessel near one or more branch vessels

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/020,869 1998-02-09
US09/020,869 US6395018B1 (en) 1998-02-09 1998-02-09 Endovascular graft and process for bridging a defect in a main vessel near one of more branch vessels

Publications (1)

Publication Number Publication Date
WO1999039663A1 true WO1999039663A1 (en) 1999-08-12

Family

ID=21801033

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/002704 WO1999039663A1 (en) 1998-02-09 1999-02-09 Endovascular graft for bridging a defect in a main vessel near one or more branch vessels

Country Status (3)

Country Link
US (1) US6395018B1 (en)
AU (1) AU2592899A (en)
WO (1) WO1999039663A1 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002015823A3 (en) * 2000-08-23 2002-08-29 Endomed Inc Method of manufacturing custom intravascular devices
US6605119B1 (en) 1999-02-04 2003-08-12 Endomed, Inc. Method of making large diameter vascular prostheses and vascular prosthesis made by said method
WO2004026181A1 (en) * 2002-09-20 2004-04-01 Gore Enterprise Holdings, Inc. Medical device amenable to fenestration
WO2005013854A1 (en) * 2003-08-12 2005-02-17 Jotec Gmbh Stent for implantation in a blood vessel, especially in the region of the aortic arch
US8267989B2 (en) 2004-01-30 2012-09-18 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
US8920488B2 (en) 2007-12-20 2014-12-30 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having a stable architecture
US9095458B2 (en) 2003-10-10 2015-08-04 Cook Medical Technologies Llc Fenestrated stent grafts
US9320627B2 (en) 2007-05-23 2016-04-26 Abbott Laboratories Vascular Enterprises Limited Flexible stent with torque-absorbing connectors
WO2016109753A1 (en) * 2014-12-31 2016-07-07 Cordis Corporation Sectional inserts for trunk section in endoprosthesis for aortic aneurysm
US9517146B2 (en) 1998-09-05 2016-12-13 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
US9867727B2 (en) 1998-02-09 2018-01-16 Trivascular, Inc. Endovascular graft
EP3284439A1 (en) * 2012-02-27 2018-02-21 Hiroshima University Stent graft
US10959826B2 (en) 2014-10-16 2021-03-30 Cook Medical Technology LLC Support structure for scalloped grafts

Families Citing this family (184)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7341598B2 (en) 1999-01-13 2008-03-11 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US8211167B2 (en) 1999-12-06 2012-07-03 Boston Scientific Scimed, Inc. Method of using a catheter with attached flexible side sheath
US6599316B2 (en) 1996-11-04 2003-07-29 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6325826B1 (en) 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6835203B1 (en) 1996-11-04 2004-12-28 Advanced Stent Technologies, Inc. Extendible stent apparatus
US7591846B2 (en) 1996-11-04 2009-09-22 Boston Scientific Scimed, Inc. Methods for deploying stents in bifurcations
US6692483B2 (en) 1996-11-04 2004-02-17 Advanced Stent Technologies, Inc. Catheter with attached flexible side sheath
AUPP083597A0 (en) * 1997-12-10 1998-01-08 William A Cook Australia Pty Ltd Endoluminal aortic stents
US6660030B2 (en) 1998-12-11 2003-12-09 Endologix, Inc. Bifurcation graft deployment catheter
US7655030B2 (en) 2003-07-18 2010-02-02 Boston Scientific Scimed, Inc. Catheter balloon systems and methods
US8257425B2 (en) * 1999-01-13 2012-09-04 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
DE60045193D1 (en) * 1999-01-27 2010-12-16 Boston Scient Ltd Bifurkationsstenteinführsystem
US6261316B1 (en) 1999-03-11 2001-07-17 Endologix, Inc. Single puncture bifurcation graft deployment system
US8034100B2 (en) 1999-03-11 2011-10-11 Endologix, Inc. Graft deployment system
US7074235B1 (en) * 1999-10-16 2006-07-11 Sumit Roy Low-profile, non-stented prosthesis for transluminal implantation
US7229472B2 (en) * 2000-11-16 2007-06-12 Cordis Corporation Thoracic aneurysm repair prosthesis and system
US6942692B2 (en) * 2000-11-16 2005-09-13 Cordis Corporation Supra-renal prosthesis and renal artery bypass
US20040106972A1 (en) * 2000-11-20 2004-06-03 Deaton David H. Fenestrated endovascular graft
AU2002250189A1 (en) 2001-02-26 2002-09-12 Scimed Life Systems, Inc. Bifurcated stent and delivery system
US8617231B2 (en) 2001-05-18 2013-12-31 Boston Scientific Scimed, Inc. Dual guidewire exchange catheter system
US7669799B2 (en) * 2001-08-24 2010-03-02 University Of Virginia Patent Foundation Reversible shape memory multifunctional structural designs and method of using and making the same
US7147661B2 (en) 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
CA2487934A1 (en) * 2002-05-30 2003-12-11 University Of Virginia Patent Foundation Active energy absorbing cellular metals and method of manufacturing and using the same
US9125733B2 (en) 2003-01-14 2015-09-08 The Cleveland Clinic Foundation Branched vessel endoluminal device
US7407509B2 (en) 2003-01-14 2008-08-05 The Cleveland Clinic Foundation Branched vessel endoluminal device with fenestration
JP4829098B2 (en) * 2003-01-14 2011-11-30 ザ クリーヴランド クリニック ファウンデーション Branch vessel endoluminal device
EP2065015B1 (en) 2003-04-03 2015-06-24 Cook Medical Technologies LLC Stent-graft
WO2004093745A1 (en) * 2003-04-23 2004-11-04 Cook Incorporated Devices kits, and methods for placing multiple intraluminal medical devices in a body vessel
US20060286342A1 (en) * 2003-05-28 2006-12-21 Elzey Dana M Re-entrant cellular multifunctional structure for energy absorption and method of manufacturing and using the same
US8298280B2 (en) 2003-08-21 2012-10-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
CA2540815C (en) * 2003-10-10 2011-10-04 The Cleveland Clinic Foundation Endoluminal prosthesis with interconnectable modules
ATE402666T1 (en) * 2003-10-10 2008-08-15 Cook Inc STRETCHABLE PROSTHETIC WINDOW
US20050096725A1 (en) * 2003-10-29 2005-05-05 Pomeranz Mark L. Expandable stent having removable slat members
US8287586B2 (en) * 2003-11-08 2012-10-16 Cook Medical Technologies Llc Flareable branch vessel prosthesis and method
US7344557B2 (en) 2003-11-12 2008-03-18 Advanced Stent Technologies, Inc. Catheter balloon systems and methods
US8014849B2 (en) * 2003-11-21 2011-09-06 Stryker Corporation Rotational markers
US7458981B2 (en) 2004-03-09 2008-12-02 The Board Of Trustees Of The Leland Stanford Junior University Spinal implant and method for restricting spinal flexion
US8523904B2 (en) 2004-03-09 2013-09-03 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for constraint of spinous processes with attachment
US8007528B2 (en) * 2004-03-17 2011-08-30 Boston Scientific Scimed, Inc. Bifurcated stent
ATE491416T1 (en) 2004-03-31 2011-01-15 Cook Inc STENT DEPOSITION DEVICE
US8048140B2 (en) 2004-03-31 2011-11-01 Cook Medical Technologies Llc Fenestrated intraluminal stent system
JP5054524B2 (en) 2004-06-08 2012-10-24 アドバンスド ステント テクノロジーズ, インコーポレイテッド Stent with protruding branch for branch pipe
AU2005254104B2 (en) * 2004-06-15 2010-08-26 Cook Incorporated Stent graft with internal tube
DE102004044435A1 (en) * 2004-09-14 2006-03-30 Siemens Ag Method and device for diagnosis and therapy of the aortic aneurysm
US7147659B2 (en) * 2004-10-28 2006-12-12 Cordis Neurovascular, Inc. Expandable stent having a dissolvable portion
US7156871B2 (en) * 2004-10-28 2007-01-02 Cordis Neurovascular, Inc. Expandable stent having a stabilized portion
US9427340B2 (en) * 2004-12-14 2016-08-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US7306623B2 (en) * 2005-01-13 2007-12-11 Medtronic Vascular, Inc. Branch vessel graft design and deployment method
US8480728B2 (en) * 2005-05-26 2013-07-09 Boston Scientific Scimed, Inc. Stent side branch deployment initiation geometry
US20060271161A1 (en) * 2005-05-26 2006-11-30 Boston Scientific Scimed, Inc. Selective treatment of stent side branch petals
US8317855B2 (en) * 2005-05-26 2012-11-27 Boston Scientific Scimed, Inc. Crimpable and expandable side branch cell
EP1915106B1 (en) * 2005-08-18 2018-04-04 Cook Medical Technologies LLC Method of manufacturing fenestrated stent grafts
US8038706B2 (en) * 2005-09-08 2011-10-18 Boston Scientific Scimed, Inc. Crown stent assembly
US8043366B2 (en) 2005-09-08 2011-10-25 Boston Scientific Scimed, Inc. Overlapping stent
US7731741B2 (en) 2005-09-08 2010-06-08 Boston Scientific Scimed, Inc. Inflatable bifurcation stent
US20070112418A1 (en) * 2005-11-14 2007-05-17 Boston Scientific Scimed, Inc. Stent with spiral side-branch support designs
US8435284B2 (en) 2005-12-14 2013-05-07 Boston Scientific Scimed, Inc. Telescoping bifurcated stent
US8343211B2 (en) 2005-12-14 2013-01-01 Boston Scientific Scimed, Inc. Connectors for bifurcated stent
US7540881B2 (en) 2005-12-22 2009-06-02 Boston Scientific Scimed, Inc. Bifurcation stent pattern
CN101378708B (en) * 2006-02-09 2012-01-11 阿兰·迪比 System for treating lesions on a blood vessel bifurcation
US20070191930A1 (en) * 2006-02-15 2007-08-16 Paul Lucas Endovascular graft adapter
US8821561B2 (en) 2006-02-22 2014-09-02 Boston Scientific Scimed, Inc. Marker arrangement for bifurcation catheter
US20070208411A1 (en) * 2006-03-06 2007-09-06 Boston Scientific Scimed, Inc. Bifurcated stent with surface area gradient
US7833264B2 (en) * 2006-03-06 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent
US20070208419A1 (en) * 2006-03-06 2007-09-06 Boston Scientific Scimed, Inc. Bifurcation stent with uniform side branch projection
US8298278B2 (en) * 2006-03-07 2012-10-30 Boston Scientific Scimed, Inc. Bifurcated stent with improvement securement
US9757260B2 (en) * 2006-03-30 2017-09-12 Medtronic Vascular, Inc. Prosthesis with guide lumen
CA2649705C (en) 2006-04-19 2015-12-01 William A. Cook Australia Pty. Ltd Twin bifurcated stent graft
US8828074B2 (en) * 2006-04-21 2014-09-09 Medtronic Vascular, Inc. Stent graft having short tube graft for branch vessel
WO2007139814A2 (en) 2006-05-23 2007-12-06 University Of Virginia Patent Foundation Method and apparatus for jet blast deflection
EP2051673A2 (en) 2006-06-23 2009-04-29 Boston Scientific Limited Bifurcated stent with twisted hinges
US8216267B2 (en) * 2006-09-12 2012-07-10 Boston Scientific Scimed, Inc. Multilayer balloon for bifurcated stent delivery and methods of making and using the same
US7951191B2 (en) 2006-10-10 2011-05-31 Boston Scientific Scimed, Inc. Bifurcated stent with entire circumferential petal
WO2008051802A2 (en) * 2006-10-19 2008-05-02 Simpirica Spine, Inc. Methods and systems for constraint of multiple spine segments
US8162982B2 (en) 2006-10-19 2012-04-24 Simpirica Spine, Inc. Methods and systems for constraint of multiple spine segments
US8029541B2 (en) 2006-10-19 2011-10-04 Simpirica Spine, Inc. Methods and systems for laterally stabilized constraint of spinous processes
US8187307B2 (en) * 2006-10-19 2012-05-29 Simpirica Spine, Inc. Structures and methods for constraining spinal processes with single connector
US8206429B2 (en) 2006-11-02 2012-06-26 Boston Scientific Scimed, Inc. Adjustable bifurcation catheter incorporating electroactive polymer and methods of making and using the same
US7842082B2 (en) 2006-11-16 2010-11-30 Boston Scientific Scimed, Inc. Bifurcated stent
US8523931B2 (en) 2007-01-12 2013-09-03 Endologix, Inc. Dual concentric guidewire and methods of bifurcated graft deployment
US7959668B2 (en) 2007-01-16 2011-06-14 Boston Scientific Scimed, Inc. Bifurcated stent
CN101715329B (en) 2007-03-05 2012-11-14 恩多斯潘有限公司 Multi-component expandable supportive bifurcated endoluminal grafts and methods for using same
US8118861B2 (en) * 2007-03-28 2012-02-21 Boston Scientific Scimed, Inc. Bifurcation stent and balloon assemblies
US8647376B2 (en) * 2007-03-30 2014-02-11 Boston Scientific Scimed, Inc. Balloon fold design for deployment of bifurcated stent petal architecture
US20110172708A1 (en) * 2007-06-22 2011-07-14 Simpirica Spine, Inc. Methods and systems for increasing the bending stiffness of a spinal segment with elongation limit
US20100036424A1 (en) 2007-06-22 2010-02-11 Simpirica Spine, Inc. Methods and systems for increasing the bending stiffness and constraining the spreading of a spinal segment
JP2010530780A (en) * 2007-06-22 2010-09-16 シンピライカ スパイン, インコーポレイテッド Method and device for controlled flexion restriction of spinal segments
US20090030502A1 (en) * 2007-07-26 2009-01-29 Jichao Sun Socket For Fenestrated Tubular Prosthesis
US8486134B2 (en) 2007-08-01 2013-07-16 Boston Scientific Scimed, Inc. Bifurcation treatment system and methods
US7959669B2 (en) 2007-09-12 2011-06-14 Boston Scientific Scimed, Inc. Bifurcated stent with open ended side branch support
US8936567B2 (en) 2007-11-14 2015-01-20 Boston Scientific Scimed, Inc. Balloon bifurcated lumen treatment
US8540758B2 (en) * 2007-11-27 2013-09-24 Vimal I. Nanavati Bifurcation stent and delivery system
US7833266B2 (en) 2007-11-28 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment
US8277501B2 (en) 2007-12-21 2012-10-02 Boston Scientific Scimed, Inc. Bi-stable bifurcated stent petal geometry
US20090164001A1 (en) * 2007-12-21 2009-06-25 Biggs David P Socket For Fenestrated Tubular Prosthesis
EP2242456A2 (en) 2007-12-31 2010-10-27 Boston Scientific Scimed, Inc. Bifurcation stent delivery system and methods
WO2009105699A1 (en) 2008-02-22 2009-08-27 Endologix, Inc. Design and method of placement of a graft or graft system
US8236040B2 (en) 2008-04-11 2012-08-07 Endologix, Inc. Bifurcated graft deployment systems and methods
US20090259290A1 (en) * 2008-04-14 2009-10-15 Medtronic Vascular, Inc. Fenestration Segment Stent-Graft and Fenestration Method
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US8932340B2 (en) 2008-05-29 2015-01-13 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
US8377108B2 (en) 2008-06-02 2013-02-19 Boston Scientific Scimed, Inc. Staggered two balloon bifurcation catheter assembly and methods
US8827954B2 (en) 2008-06-05 2014-09-09 Boston Scientific Scimed, Inc. Deflatable bifurcated device
US8187305B2 (en) * 2008-06-06 2012-05-29 Simpirica Spine, Inc. Methods and apparatus for deploying spinous process constraints
US8308771B2 (en) * 2008-06-06 2012-11-13 Simpirica Spine, Inc. Methods and apparatus for locking a band
EP2293838B1 (en) 2008-07-01 2012-08-08 Endologix, Inc. Catheter system
US8353943B2 (en) * 2008-08-29 2013-01-15 Cook Medical Technologies Llc Variable weave graft with metal strand reinforcement for in situ fenestration
US20100114301A1 (en) * 2008-10-31 2010-05-06 Vioptix, Inc. Vessel Right Sizer
US20100114292A1 (en) * 2008-10-31 2010-05-06 Vioptix, Inc. Vessel Extender
WO2010104975A1 (en) * 2009-03-10 2010-09-16 Simpirica Spine, Inc. Surgical tether apparatus and methods of use
EP2405840B1 (en) 2009-03-10 2024-02-21 Empirical Spine, Inc. Surgical tether apparatus
JP2012520131A (en) * 2009-03-10 2012-09-06 シンピライカ スパイン, インコーポレイテッド Surgical tether device and method of use
US8668719B2 (en) * 2009-03-30 2014-03-11 Simpirica Spine, Inc. Methods and apparatus for improving shear loading capacity of a spinal segment
US20100274276A1 (en) * 2009-04-22 2010-10-28 Ricky Chow Aneurysm treatment system, device and method
EP2429452B1 (en) * 2009-04-28 2020-01-15 Endologix, Inc. Endoluminal prosthesis system
EP2424447A2 (en) 2009-05-01 2012-03-07 Endologix, Inc. Percutaneous method and device to treat dissections
US10772717B2 (en) 2009-05-01 2020-09-15 Endologix, Inc. Percutaneous method and device to treat dissections
AU2009202301B8 (en) * 2009-06-10 2009-12-03 Cook Incorporated Reinforcing ring
WO2010150208A2 (en) 2009-06-23 2010-12-29 Endospan Ltd. Vascular prostheses for treating aneurysms
WO2011008989A2 (en) 2009-07-15 2011-01-20 Endologix, Inc. Stent graft
US8118856B2 (en) 2009-07-27 2012-02-21 Endologix, Inc. Stent graft
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
EP3735937A1 (en) 2009-11-30 2020-11-11 Endospan Ltd. Multi-component stent-graft system for implantation in a blood vessel with multiple branches
EP2509535B1 (en) 2009-12-08 2016-12-07 Endospan Ltd Endovascular stent-graft system with fenestrated and crossing stent-grafts
US9468517B2 (en) 2010-02-08 2016-10-18 Endospan Ltd. Thermal energy application for prevention and management of endoleaks in stent-grafts
US20110218609A1 (en) * 2010-02-10 2011-09-08 Trivascular, Inc. Fill tube manifold and delivery methods for endovascular graft
US8870939B2 (en) 2010-08-21 2014-10-28 Cook Medical Technologies Llc Prosthesis having pivoting fenestration
CA2748206C (en) 2010-08-21 2015-06-23 Blayne A. Roeder Prosthesis having pivoting fenestration
US8771336B2 (en) 2010-08-21 2014-07-08 Cook Medical Technologies Llc Endoluminal prosthesis comprising a valve replacement and at least one fenestration
US8702786B2 (en) 2010-08-21 2014-04-22 Cook Medical Technologies Llc Prosthesis having pivoting fenestration
EP2635241B1 (en) 2010-11-02 2019-02-20 Endologix, Inc. Apparatus for placement of a graft or graft system
BR112013011807A2 (en) * 2010-11-15 2016-11-01 Endovascular Dev Ab '' set with guidewire and fixative for attachment to a blood vessel and tubular element ''
EP2640319B1 (en) 2010-11-16 2016-10-19 TriVascular, Inc. Advanced endovascular graft and delivery system
WO2012068298A1 (en) 2010-11-17 2012-05-24 Endologix, Inc. Devices and methods to treat vascular dissections
JP6294669B2 (en) 2011-03-01 2018-03-14 エンドロジックス、インク Catheter system and method of use thereof
WO2013030818A2 (en) 2011-08-28 2013-03-07 Endospan Ltd. Stent-grafts with post-deployment variable axial and radial displacement
WO2013065040A1 (en) 2011-10-30 2013-05-10 Endospan Ltd. Triple-collar stent-graft
US20130289690A1 (en) 2011-11-01 2013-10-31 Hira V. Thapliyal Personalized prosthesis and methods of use
US8728148B2 (en) 2011-11-09 2014-05-20 Cook Medical Technologies Llc Diameter reducing tie arrangement for endoluminal prosthesis
ES2675177T3 (en) 2011-11-11 2018-07-09 Bolton Medical, Inc. Universal endovascular grafts
WO2013074990A1 (en) 2011-11-16 2013-05-23 Bolton Medical, Inc. Device and method for aortic branched vessel repair
WO2013084235A2 (en) 2011-12-04 2013-06-13 Endospan Ltd. Branched stent-graft system
GB2499377B (en) * 2012-02-01 2014-04-30 Cook Medical Technologies Llc Implantable medical device
EP2811939B8 (en) 2012-02-10 2017-11-15 CVDevices, LLC Products made of biological tissues for stents and methods of manufacturing
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US9811613B2 (en) 2012-05-01 2017-11-07 University Of Washington Through Its Center For Commercialization Fenestration template for endovascular repair of aortic aneurysms
US9770350B2 (en) 2012-05-15 2017-09-26 Endospan Ltd. Stent-graft with fixation elements that are radially confined for delivery
US10092391B2 (en) 2012-12-26 2018-10-09 The Cleveland Clinic Foundation Endoluminal prosthesis having modular branches and methods of deployment
WO2014108895A2 (en) 2013-01-08 2014-07-17 Endospan Ltd. Minimization of stent-graft migration during implantation
EP2953580A2 (en) 2013-02-11 2015-12-16 Cook Medical Technologies LLC Expandable support frame and medical device
US9668892B2 (en) 2013-03-11 2017-06-06 Endospan Ltd. Multi-component stent-graft system for aortic dissections
US10265202B2 (en) 2013-03-14 2019-04-23 Cook Medical Technologies Llc Prosthesis having an everting pivoting fenestration
US9907684B2 (en) 2013-05-08 2018-03-06 Aneuclose Llc Method of radially-asymmetric stent expansion
US10603197B2 (en) 2013-11-19 2020-03-31 Endospan Ltd. Stent system with radial-expansion locking
US8998971B1 (en) * 2014-01-28 2015-04-07 Sanford Health Pararenal stent graft and methods for use
EP2995277B1 (en) 2014-09-10 2018-11-28 Cook Medical Technologies LLC Stent graft having movable fenestrated tubular bridge
WO2016049037A1 (en) 2014-09-23 2016-03-31 Bolton Medical, Inc. Vascular repair devices and methods of use
WO2016098113A1 (en) 2014-12-18 2016-06-23 Endospan Ltd. Endovascular stent-graft with fatigue-resistant lateral tube
EP3285687A4 (en) 2015-04-22 2019-07-10 AneuMed, Inc. Personalized prosthesis and methods of deployment
US10583020B2 (en) 2015-05-27 2020-03-10 Trivascular, Inc. Balloon assisted endoluminal prosthesis deployment
US11129737B2 (en) 2015-06-30 2021-09-28 Endologix Llc Locking assembly for coupling guidewire to delivery system
WO2017019913A1 (en) 2015-07-30 2017-02-02 Trivascular, Inc. Endoluminal prosthesis deployment devices and methods
US10905540B2 (en) 2015-11-12 2021-02-02 Endospan Ltd. Stent-grafts systems with skirt
DE102015121818A1 (en) * 2015-12-15 2017-06-22 Biotronik Se & Co. Kg Implementation of a medical electronic device, method for producing such and medical electronic device
US10390932B2 (en) * 2016-04-05 2019-08-27 Bolton Medical, Inc. Stent graft with internal tunnels and fenestrations and methods of use
ES2905193T3 (en) 2016-05-25 2022-04-07 Bolton Medical Inc Stent grafts for the treatment of aneurysms
AU2017285041A1 (en) * 2016-06-13 2019-01-31 Aortica Corporation Systems, devices, and methods for marking and/or reinforcing fenestrations in prosthetic implants
CN109789009B (en) 2016-08-02 2021-04-16 主动脉公司 Systems, devices, and methods for coupling a prosthetic implant to an fenestration
US10729532B2 (en) 2017-02-14 2020-08-04 Cook Medical Technologies Llc Bifurcated prosthesis with an internal limb
US10772719B2 (en) 2017-02-14 2020-09-15 Cook Medical Technologies Llc Method of making a contoured internal limb for a prosthesis and prosthesis with a contoured internal limb
WO2018156848A1 (en) 2017-02-24 2018-08-30 Bolton Medical, Inc. Vascular prosthesis with crimped adapter and methods of use
EP3534837A1 (en) 2017-02-24 2019-09-11 Bolton Medical, Inc. Constrainable stent graft, delivery system and methods of use
WO2018156849A1 (en) 2017-02-24 2018-08-30 Bolton Medical, Inc. Vascular prosthesis with fenestration ring and methods of use
WO2018156842A1 (en) 2017-02-24 2018-08-30 Bolton Medical, Inc. System and method to radially constrict a stent graft
CN110114037B (en) 2017-02-24 2022-07-12 波顿医疗公司 Radially adjustable stent graft delivery system
WO2018156851A1 (en) 2017-02-24 2018-08-30 Bolton Medical, Inc. Vascular prosthesis with moveable fenestration
WO2018156850A1 (en) 2017-02-24 2018-08-30 Bolton Medical, Inc. Stent graft with fenestration lock
WO2018156847A1 (en) 2017-02-24 2018-08-30 Bolton Medical, Inc. Delivery system and method to radially constrict a stent graft
EP3534848B1 (en) 2017-02-24 2023-06-28 Bolton Medical, Inc. Stent graft delivery system with constricted sheath
CN109843226B (en) 2017-02-24 2022-05-17 波顿医疗公司 Delivery systems and methods of use for radially contracting stent grafts
CN115813605A (en) 2017-09-25 2023-03-21 波尔顿医疗公司 Systems, devices, and methods for coupling a prosthetic implant to an fenestration
CN110121319B (en) 2017-10-31 2023-05-09 波顿医疗公司 Distal torque component, delivery system, and method of use thereof
US10888414B2 (en) 2019-03-20 2021-01-12 inQB8 Medical Technologies, LLC Aortic dissection implant

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001761A2 (en) * 1993-07-08 1995-01-19 Fogarty Thomas J Internal graft prosthesis and delivery system
EP0646365A1 (en) * 1993-10-01 1995-04-05 Juan Carlos Parodi Aortic graft, and method and apparatus for repairing an abdominal aortic aneurysm
US5425765A (en) * 1993-06-25 1995-06-20 Tiefenbrun; Jonathan Surgical bypass method
WO1997009008A1 (en) * 1995-09-08 1997-03-13 Medtronic, Inc. Method and apparatus for conformably sealing prostheses within body lumens
WO1997025001A1 (en) * 1996-01-08 1997-07-17 Jean Marc Denis Aortoiliac endoprosthesis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657744A (en) 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US4512338A (en) 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4562596A (en) 1984-04-25 1986-01-07 Elliot Kornberg Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair
US5464450A (en) * 1991-10-04 1995-11-07 Scimed Lifesystems Inc. Biodegradable drug delivery vascular stent
US5316023A (en) * 1992-01-08 1994-05-31 Expandable Grafts Partnership Method for bilateral intra-aortic bypass
US5370618A (en) 1992-11-20 1994-12-06 World Medical Manufacturing Corporation Pulmonary artery polyurethane balloon catheter
US5399352A (en) * 1993-04-14 1995-03-21 Emory University Device for local drug delivery and methods for using the same
US5653743A (en) * 1994-09-09 1997-08-05 Martin; Eric C. Hypogastric artery bifurcation graft and method of implantation
US5609628A (en) * 1995-04-20 1997-03-11 Keranen; Victor J. Intravascular graft and catheter
US5591195A (en) 1995-10-30 1997-01-07 Taheri; Syde Apparatus and method for engrafting a blood vessel
US5824040A (en) * 1995-12-01 1998-10-20 Medtronic, Inc. Endoluminal prostheses and therapies for highly variable body lumens
US5617878A (en) 1996-05-31 1997-04-08 Taheri; Syde A. Stent and method for treatment of aortic occlusive disease
US5676697A (en) * 1996-07-29 1997-10-14 Cardiovascular Dynamics, Inc. Two-piece, bifurcated intraluminal graft for repair of aneurysm
US5855600A (en) * 1997-08-01 1999-01-05 Inflow Dynamics Inc. Flexible implantable stent with composite design

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5425765A (en) * 1993-06-25 1995-06-20 Tiefenbrun; Jonathan Surgical bypass method
WO1995001761A2 (en) * 1993-07-08 1995-01-19 Fogarty Thomas J Internal graft prosthesis and delivery system
EP0646365A1 (en) * 1993-10-01 1995-04-05 Juan Carlos Parodi Aortic graft, and method and apparatus for repairing an abdominal aortic aneurysm
WO1997009008A1 (en) * 1995-09-08 1997-03-13 Medtronic, Inc. Method and apparatus for conformably sealing prostheses within body lumens
WO1997025001A1 (en) * 1996-01-08 1997-07-17 Jean Marc Denis Aortoiliac endoprosthesis

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10548750B2 (en) 1998-02-09 2020-02-04 Trivascular, Inc. Endovascular graft
US9867727B2 (en) 1998-02-09 2018-01-16 Trivascular, Inc. Endovascular graft
US10420637B2 (en) 1998-09-05 2019-09-24 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
US9517146B2 (en) 1998-09-05 2016-12-13 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
US6605119B1 (en) 1999-02-04 2003-08-12 Endomed, Inc. Method of making large diameter vascular prostheses and vascular prosthesis made by said method
EP1745761A1 (en) * 2000-08-23 2007-01-24 LeMaitre Acquisition LLC Method of manufacturing custom intravascular devices
WO2002015823A3 (en) * 2000-08-23 2002-08-29 Endomed Inc Method of manufacturing custom intravascular devices
WO2004026181A1 (en) * 2002-09-20 2004-04-01 Gore Enterprise Holdings, Inc. Medical device amenable to fenestration
US9694108B2 (en) 2002-09-20 2017-07-04 W. L. Gore & Associates, Inc. Medical device ameneable to fenestration
WO2005013854A1 (en) * 2003-08-12 2005-02-17 Jotec Gmbh Stent for implantation in a blood vessel, especially in the region of the aortic arch
US8668729B2 (en) 2003-08-12 2014-03-11 Jotec Gmbh Stent for implantation in a blood vessel, especially in the region of the aortic arch
US10376395B2 (en) 2003-10-10 2019-08-13 Cook Medical Technologies Llc Fenestrated stent grafts
US9095458B2 (en) 2003-10-10 2015-08-04 Cook Medical Technologies Llc Fenestrated stent grafts
US9539123B2 (en) 2003-10-10 2017-01-10 Cook Medical Technologies Llc Fenestrated stent grafts
US8267989B2 (en) 2004-01-30 2012-09-18 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
US9320627B2 (en) 2007-05-23 2016-04-26 Abbott Laboratories Vascular Enterprises Limited Flexible stent with torque-absorbing connectors
US8920488B2 (en) 2007-12-20 2014-12-30 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having a stable architecture
EP3284439A1 (en) * 2012-02-27 2018-02-21 Hiroshima University Stent graft
US10828144B2 (en) 2012-02-27 2020-11-10 Hiroshima University Stent graft
US10959826B2 (en) 2014-10-16 2021-03-30 Cook Medical Technology LLC Support structure for scalloped grafts
WO2016109763A1 (en) * 2014-12-31 2016-07-07 Cordis Cororation Circular sectional inserts for insertion with a trunk section in endoprosthesis for aortic aneurysm
WO2016109753A1 (en) * 2014-12-31 2016-07-07 Cordis Corporation Sectional inserts for trunk section in endoprosthesis for aortic aneurysm

Also Published As

Publication number Publication date
US6395018B1 (en) 2002-05-28
AU2592899A (en) 1999-08-23

Similar Documents

Publication Publication Date Title
US6395018B1 (en) Endovascular graft and process for bridging a defect in a main vessel near one of more branch vessels
CN109789009B (en) Systems, devices, and methods for coupling a prosthetic implant to an fenestration
US20200188144A1 (en) Personalized prosthesis and methods of use
CN111148484B (en) Systems, devices, and methods for coupling a prosthetic implant to an open window
EP1435878B1 (en) System for fixation of endoluminal devices
US20050171598A1 (en) Aorta and branch vessel stent grafts and method
US20090264985A1 (en) Branch Vessel Suture Stent System and Method
PL222299B1 (en) Bifurcation stent system for endovascular stent implantation and a method for stent implantation for bifurcation
US20140180394A1 (en) Endoluminal prosthesis having modular branches and methods of deployment
Higashiura et al. Initial experience of branched endovascular graft for abdominal aortic aneurysm with complex anatomy of proximal neck: planning and technical considerations
US20240074843A1 (en) Vascular Stent Connector, Vascular Stent-Graft Employing Same, and Methods of Making Same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase